Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Yersinia pestis biovar Medievalis str. 91001, 91001

>YP2730 hypothetical protein
MEDIIKFSGPIFIAFLSSPILLYSLVGSVWFFIFNKLPKFNKFIIKYLSI
PMFLSFIVSFPISLYVDYKLKSNGYVVCDRISWMSPNTYVKDLSLCR
>YP3013 Fimbrial protein
MKKNIFLTLRSERYKAGLLLLLLLLLCTTSKPSFAALQVNSCSLAVSGAG
GETPFVIKALPVTLTNGFVLGSMNFSVVTTFTKTGTTADYLYLGGWSMLA
GGAVMPVSTGVPGVKMSVNVSDALFGGYEWGNTEKATQSLFVPGTKITIA
NRVTVQLIVTDASVYQGGVINWFNVARSFALVSGNAQVWSTKSVATGGSR
CGDMVTFNIGSTNIVLPPPTVATCDLGATDIVVALDPIDTSSLQTQGDRA
GGQAFSIPLGSCAKDAKPYITFTDSSNKANRTNILSLSPSSTATGVGLVL
EKSDGNLVTFGAENASVSASNVGQFLIGTSTAAGGSMPLNLTARYIRAEG
VLKSGNVKADAIFTVAYP
>YP2301 hypothetical protein
MIGSTATADKNTLDTGTLGFSDIDNQADFKVEHQSVGISTGGNIGSQFVG
NMANGLLVGANNEGHADSTTHAAVSEGMRAALLDIRVFMMSIYGVFYQSV
EDIDFFIRETKEFSFPEDYQVPEHYNYRRE
>YP1803 Predicted outer membrane protein
MLKHFRLGLFTANVQADTGSQHSFSRVPAAAINPITLAIVVAFSTIALPP
MALAACTSPGVGTYVCEGENTDGIILSGTDIAVETQPGFSIIVPENGDPA
LSLVGSGTISYLDTNSSALDTTGADSLYIQNDTHTTGQSSSINVQTNGSM
GSGINISNHSGADSTVQVDVSGTLFGDLNGSPALLIYSSAENNSTILMNI
NTIFGDVGIRSDNTSFNGTAITNVDIANDINATYSGATINNSGSGGTSVV
NFNSKSIITELDALNIYNTNYSGAVITNVDIDGDVISTTSQATSFYNDAY
NGSANFTFRANNVTGEYSGISINNSSHNSANNNHDNAVITDILLTGDLTS
TSGSGLQINSYMDDGDIKVSAQLENIYSYYEALSVRADTLTGNLQFNIDV
SGNIVAENGLGFMVMGGASEGNSTMIINANNISSGSQALNIYNYSGLGSA
FTAVTATGHLVSEQGIGAMFSTYVSQGDATAVINLNDITTAGSGVKIDTI
ANGGNSTTYLTVVGQINSSLYDGIDLRATATEGNTLVSIDVNNIASEYDA
IHLDNKNYTTGADNGTSTIDLITRGALVSQQGYGINIETNTADTYVTVGG
LVHGGNGTAIGIHRLDNIQTSATLELQSGYALEGVTQALVFNGSYAEIND
AALDLANSHLVLGGAGDAAFDLTRIDNREEAILDGDPNRITGFGTLTKTN
NSIWTLTGANMADGDANAFLSANIAGGILVLDNATLGLTPDAGALTGATV
NRLSAADIAADPTLVATETGALTLAEGGALSSLGDSVLSGNLISAGGILL
SNHYTGGNGAATDDRLTVTGTYFGENNGSGEGAWLALDTVLGDDDSATDR
LVINGDATGTTSVRVNNAGGLGDKTLNGINLITVDGLAQDDTFLLAGDYV
TTDGYQAVVGGAYAYTLQADGEAATAGRNWYLSSELMLTEGVRYQAGVPL
YEQYPQVLAALNTLPTLQQRVGNRYGAPGALADLDFDNNQWAWGRIEGSH
QVTDPARSTSGSQREIDVWKLQTGIDVPLYQSQDGSLLTGGVNFSYGKAK
ADIHSFFGDGRINSAGYGLGTSLTWYGNNGVYVDGQLQTMWFDSDLSSRT
AGHAVASGNNGRGYTSAIEAGKGYALGNGLSLTPQMQVTYSRVDFDTFRD
PFDSEVSLQEGDSLRGRIGVSLDKETTWSAKDGTTRRSHIYSHLDLHNEF
LNGSKVQVSGVEFATRDERQSVGLGAGGTYEWQNGRYAVYGNVNLLGATR
NVSDNYAVGGTIGARVSW
>YP1206 putative exported protein
MFTKSNFKKSVVIITAIFSGSVFADVNIGDFNTGVIGNGTAVGNNNSLGG
STNGVVVGNGGSLSNSINGVVIGNGSVSDGDGVSVGGGTSTNGGIAIGSG
SNATRSDEMNIGDRQITGVKAGVADTDAANVGQLVAKAGETLNSANIYVD
NQATETLNNANIYTDNKATETINNANTYTDNKSSETLNSANSYTDNKSSE
TLNSANTYTDSKTAEIFNTTKTYMDGKSKETLNNTYDYVDSKVSSIVYDV
NSYTDKTVNTAFETSLSDAKSYVDDKYNQLSDKVNKNFNKTNAGISGAMA
MSGIPQKFGYEKSFGMAIGAYRGQSALAVGGDWNINHKTITRVNVSADTE
GGVGVAAGFAFGIN
>YP0840 putative membrane protein
MLEEIAVNPNWFWLSLGGLLLAAEMLGASGYLLWSGIAAVLVGVLVWLFP
FSWEMQGVLFSILTVVSAFLWWYWLSKRTKPQPAMLNQRNHQLLGIRATL
TEPTVDGYGRMKVGDSSWRIYCATELNPGTEVEVILVEGNTLHVRAVNR
>YP0465 putative exported protein
MHIQFREPISTSPAQPDAGRQHLFSRVPAAVMNPITLAIIVAFSTLVLPQ
TAWAACNSSGVGTYVCEGENNTAISLFGTDIAVETRPGFGITEHEITDSA
LSLTGSGTISYLDTNSSALDTDSRYSLYIKNDTLITEQSASINVQSNGSI
SSGVYIDNQSSDDSTIRVDLSGILSSSLSGAPALSIFSSAGNDSTIILNT
HAISGVTGIQSDNNSQNGATITHVDVTGDINVENSGVSIRNAANGGTSII
NFNSKSINTEYNSFYIQNTNYVGGVITDINIDGDISSANSQAARIYNYTN
GGLASLRFRANNVTGSTGLYIDNSSQNGAVTDIILTGDLTATSGSALQAN
AYSDEGNIETAIKLNNVYSLYDALNISDYTRSGNILHDLDISGTITAENG
TGIKVMGAAGEGSSTMLINVNNITSSSQSLDINNYNFLGSAFSAITATGH
LTAEWGQGAMLQTHSSLGDATTLIHFNDITAMSSGISLINEANQGTSTAD
ITVTGQINVSHGEGITLNALTTDGRTLVNVDVNNIASEYDAIRLYNYNYN
DNYATGVDDGTGADNGTSTIDLITRGALVSQQGYGINIETNTADTYVTVG
GLVHGGNGTAIGIHRLDNIQTSATLELQSGYALEGVTQALVFTGSYAEIN
DAALDLANSHLVLGGAGDAAFDLTRIDNREEAILDGDPNRITGFGTLTKT
NNSIWTLTGANMADGDANAFLSANIAGGILVLDNATLGLTPDAGALTGAT
VNRLSAADIAADPTRVATETGALTLAEGGALSSLGDSVLSGNLISAGGIL
LSNHYTGGNGAATDDRLTVTGTYFGENNGSGEGAWLALDTVLGDDDSATD
RLVINGDATGTTSVRVNNAGGLGDKTLNGINLITVDGLAQDDTFLLAGDY
VTTDGYQAVVAGAYAYTLQADGEAATAGRNWYLSSELMLTEGVRYQVGVP
LYEQYPQVLAALNTLPTLQQRVGNRYGAPGALADLNFDDNQWAWGRIEGS
HQVTDPARSTSGSQREIDVWKLQTGIDVPLYQSQGGSLLTGGVNFTYGKA
KADIHSFFGDGRINSAGYGLGTSLTWYGNNGVYVDGQLQTMWFDSDLSSR
TAGHAVASGNNGRGYTSAIEAGKGYTLSHGLSLTPQMQVTYSRVDFDTFR
DPFDSEVSLQEGDSLRGRLGVSLNKETTWSAKDGTTRRSHIYSHLDLHNE
FLNGSKVQVSGVEFATRDERQSVGLGAGGTYEWQNGRYAVYGNVNLLGAT
RNISDNYAVGGTIGARVSW
>YP3006 hypothetical protein
MTTGIKIMMFMGVLFIKIDITPLSNHGINIYNGGSMQLILNKDLINKKDN
REKSAVVIISTRKGLKDKISEYVRLADIKNIKEIDDDIFSAASILIPDNV
KGIIIDINENHDINTILDLMKVHTPRDCWCILVGDIDSISIAQQFIERGI
LYLHIQSQLADLTQNLLKGIQIESDRKAFFISILGCRGGIGTTLLSYQLA
HVITQIKKSPTLLLQGNQGSQDLDLITEKKMGEDITGYQKNFDLMRGNER
KLSEVNEHNNKKHNFIIFDQPIHNARKEKTLDYISNSNCIILLIDHSMMS
VRVAKEFIDTLERFKRDNRQAIRLFICLNENRPITKDMLTTSDIQSLLGH
SIDTAIPYINNAKNSLNSPDYFGRKKTKVVELAKQSLGININLSSHTNMW
IREKLNKLFK
>YP3225 putative lipoprotein
MYKKIVRFLAVGLLVAGLSACDNSSDNNVGQTVSLLDGKVTFNLPADLSD
QSGKMGNQANNMHVYANNTGDKAVIVILGEGTNEKLEVLTNRLAEQQRAR
DANLQVVTNKTININGQPFQQLDSIITSSGQKAYSSIVMGTVGNQLMTLQ
ITLPAENQQQAQTEAESIISTLKLK
>YP2999 putative membrane protein
MQKKTMITFILEKYEFFIKNRQGAILLSFMALIPVFIGLIFLSFEFSHFI
QKRAKLSDALEQASLALSTENNYRNDRASNNRNNYLVTSYAQSYLPSERF
SQPRVVNTYNESLGYTEYNASLQMNYQLALLNSYLKQTPSPTWDVNENGA
ARKYLSSIAEPIDVVFVTDFSGSMDLPFGDIERNNRITKLDELKAIFVKL
NNRIFSNDGINTIGFVPFSWGTKRISANGQVSSTYCHFPYSPKKIDGNGH
YLQRYTASNLKNIPGLDNLSGIDNLAYGQLDEDKHHAILSEIEKKHRDNE
IPTKTRDQAKNFLDKAYKVNQISTITKIVEEHIDYKETINSIDRNGETID
IPMDDILDPFFCLKETNAKSLNFDPNSKGDINEILNMKAEGGTLASSGIL
VGNKMLTESQNNNKLMIILSDGDDNTQKMSSPHDQKAGIINITQKLITEG
MCQKIKDNGIKMVFIGIGYVPDNNIIDWEKDCVGTGNFYLAKNAHELEIS
IERALVVDDEVGRNIPKS
>YP3502 Predicted ATPases involved in pili biogenesis, PilT homologs
MDMDFTSLNNQHSDLNNPVFSRIKAKRIDLENPDLASDGFNKQDFANKVA
ASVDHNASDLHLCTGFHPVLRIDGELKTFTDWPKVTAGWLNGLRRHMLSD
AQESRLQQQGQVDCAYTTVGSQRLRANIFQQRQGQSIAFRIIPAICPSLT
QLAAPPILNQLIQQDNGLILVTGATGSGKSTTLSAMISAINQQQARHIIT
LEDPIEFIHSSQSCLIQQRELGRHTHCFSRALNGALRQDPDIILLGELRD
LETIRLALTAAETGHLVLATLHTRTATQAIDRLIDVFPPEEKAVIRTQLA
ASLRGVITQKLCRQNGGGRIAVFEILTQTTAVSHLIREGKTYQLPTVIQA
GGQWGMQTFEQSIAQRQKQGVLAINH
>YP3005 putative type II secretion protein
MIVPLKIQELMRERMLANIDINKVELLVGDRNKLIGLLSQTFDDLFNNNE
YNLTTQAQKYIIEMIADEITGFGPLRELMEDDSISDIMVNGPERIFIERY
GLLKLTDRRFVNNTQLTDIAKRLMQKVNRRIDEGRPLADARLIDGSRINV
AISPIALDGTALSIRKFSKNKRRLEDLVDMGAMSSDMANFLIIAASCRVN
IIISGGTGSGKTTLLNALSKYISEDERVITLEDAAELNLEQPHVVRMETR
LAGLENTGQITMRDLVINSLRMRPDRIIIGECRGEETFEMLQAMNTGHNG
SMSTLHANTPRDAVARLESMIMMGPVNMPLITIRRNIASAINLIVQVSRM
NDGSRKIRNISEIMGMEGEHVVLQDIFTFQPASTRDDQGRIQGEFINHGL
FNRSSVRINADIHNLANELNSVFSTVSK
>YP2651 putative autotransporter
MNTNSKKTYLNIAISFILYASTAMNANADSCIDYTVTDICEQSKYAAGEF
HNIKLGDGVTAGSEDHHFVFNGEGYELYNSNANFSAQIASGTIRYTEVNN
SYFTVNAHHFPDDTIYAGRAENTTLNDSLMWVATSADQTLAKGNSMVVVS
TQMAMVDQIFVTTLNDGSLPFDPVITNSRYEDTSYEMLWGMKNEAKGWDT
KATSHDSVFVDASKQSIEANGHSIGATFYGRATQVVKAGGESQDTHLFDH
SYSWVYAEAKLTGLTEVNDAATVYLNAAATQGAYAENVVLNGEDTTLMVR
ASLDNNAYATVDNLILNGGEVVFQQSSGDQYASLNIGTLSGSGSFLFNTS
IAEGKGNFVTIANASGEHKVIVNDSGHEITSPDMTTLDLIHDLSGDATFT
LASISGANIIEVDGGTYVYSLNTWDNSARAGGNLWYLGSGLNTGTELEPE
PEEKTTPSTDAVLSMASSNQFIFDGEMQNLRFRKGDLNNNKGDGASVWGR
YLTNNTRVNAAHDAAYRLQQDGFEIGADKVLEMSSGQLVLGGFTSYSNNR
VKHARGGNSTVDSYSLGAYGTYFDNSGYYVDAVVKANRFKNSLNAHMTNG
GSVQSDYNQNAIGGSLEAGYHYSLSNNWFVEPYVRTSYYTAQDKDIALNN
GMTANIDNNRSAKGEIGTHLGTKIDLNNGAIIRPYAKVAIEREFIKSNTV
TINQVNDFNNDLSGHTAKYGLGMDINLMKQTSVYAEANYRNGTHVESPIM
ANIGFRINF
>YP2907 putative autotransporter protein
MKNSNRSPKNISRNFKHHKETSLSSKNKSPIATCVAAALFIFGSSSVIAN
LDHEGIVVGKSILNKKQSAVNAIINEGNSLVLTDSASAEHTAVNTGSIFT
LKEDSTADITSVTGGFFSLSGSSKANINTVLSGGWLEVNDDASITETTIS
SDIEKKSTVRLYQDGSATKTTVGDNGILYVSGDSRAEETHVTKGGKLIVY
SESQGPTLKNTQIAGTLTLKSDVTLEGKTEFVSSATIKTTGHLIDNQGQL
IFNSDKDIVIEAMIDGQGSLTKENPLTTLTLSSAGDAWVASYVYSGETHI
NAGNLKLANTHFFGSPISGNPNTRLILEKSTLDTTVQGSSVFIDKHSIWN
MLGDSNIHHLDILDSGRHDLNNPGKTGNQLIINGDYFSDNGTLIFHSQLA
GDDSVTDHILIKGNTGGHTNVRVINVNGEGNKTDSGIQLIEVRGISDGEF
SQVGRITAGAYEYRLGRGKDELSKNWYLSSDITDYSSDGVPEAELPGILV
LKSDNAAVFSAKLADYALQAVGGVVDSFTQPETSPPSNTPELTVPDPKRA
NAAAFSAKLADYALQTVGGVVDSFTQPETSPPSNTPELTVPDPKRANAEA
FSAKLADYALQAVGGVVDTFTSPEQTEQTTATPDSTPKSTDSAVKPASTP
KPTDLAVKPANTVISNAKTAAPKRQTLVHTPENGSYIANIAMARNLFTTR
LEDRTSHYLYKDIVTGQWQPTSMWMHTQGGRSQFGHTVEQLNIKGNYYSV
QLGGDIAQWATNEQGSGRIGMLAGLGKATNHSHSKVTSYHSRGAVDGYNL
GIYATWFADQQHNTGVYIDTLAQYSWFNNAVNGQDKAEEKYKSSGFTTSI
ESGYTFNLANSDQLSYFIQPNAQITWAGINAQTHKTADGAVVSYRNNGHF
ITRIGAKAYLQTHDTLNTKFTPFVAVNWIHQNQNTGTTISGQGIDNKIQN
STEFNVGVESQIDQQLHIWANINHQIGRYNYTDTNALVGVKYHF
>YP3003 putative exported protein
MRIIFFTLLILLGLIIILKVNSRSRRISVYNKINSRENKSKEANNDTKDK
PTVLSDFIKLPVFLSNILYLKVLIVIFILSILTILAIFNVVNINQKTLLT
IGLLSIISTLYLPRMIIKNALTKRTNNLLKSLPFFIDITAACVQSGMTIE
NSLNYTTQKFQTINTDLCLIMSKVTKRAEINGLENAIKELQYYSPAIEMK
MFCSTLQYSISFGSTVYEQLTHLSQDMREMQLLMTEESISKLSTKLTLPL
FLFILIPFVLLVISPSILELLNYVKNI
>YP3306 putative invasin
MLNYFRAILISWKWKLSHHTSRPHDVKEKGHPRKIKVVAWITLFFQFAFP
LSLSFTPAIAAANTTNSAPTSVITPVNASILPPAARATEPYTLGPGDSIQ
SIAKKYNITVDELKKLNAYRTFSKPFASLTTGDEIEVPRKESSFFSNNPN
ENNKKDVDDLLARNAMGAGKLLSNDNTSDAASNMARSAVTNEINASSQQW
LNQFGTARVQLNVDSDFKLDNSALDLLVPLKDSESSLLFTQLGVRNKDSR
NTVNIGAGIRQYQGDWMYGANTFFDNDLTGKNRRVGVGAEVATDYLKFSA
NTYFGLTGWHQSRDFSSYDERPADGFDIRTEAYLPAYPQLGGKLMYEKYR
GDEVALFGKDDRQKDPHAVTLGVNYTPVPLVTIGAEHREGKGNNNNTSVN
VQLNYRMGQPWNDQIDQSAVAANRTLAGSRYDLVERNNNIVLDYKKQELI
HLVLPDRISGSGGGAITLTAQVRAKYGFSRIEWDATPLENAGGSTSPLTQ
SSLSVTLPFYQHILRTSNTHTISAVAYDAQGNASNRAVTSIEVTRPETMV
ISHLATTIDNATANGIATNTVQATVTDGDGQPIIGQLINFAVNTQATLST
TEARTGANGTASTTLTHTVSGVSRVSVTLGSSSRSVDTTFVADESTAEIT
AANLTVTTNDSVANGSDTNVVRAKVTDAYTNAVANQSVIFSASNGATVID
QTVITNAEGIADSTLTNTTAGVSVVTATLGGQSQQVDTTFKPGSTAAISL
VKLADRAVADGIDQNEIQVVLRDGTGNAVPNVPMSIQADNGAIVVASTPN
TGVDGTINATFTNLRAGESVVSVTSPALVGMTMTMTFSADPRTAVVSTLA
AIDNNAKADGTDTNVVRAWVVDANGNSVPGVSVTFDAGNGAVLAQNPVVT
DRNGYAENTLTNLAIGTTTVKATTVTDPVGQTVNTHFVAGAVDTITLTVP
VNGAVANGVNTNSVQAVVSDSGGNPVTGATVVFSSTNATAQVTTVIGTTG
VDGIATATLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNG
AVADGADTNQVDALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGV
ASTLLTHTVAGTSNVVATVDTVNANIDTTFVAGAVATITLTTPVNGAVAD
GANSNSVQAVVSDSDGNPVTGAAVVFSSANATAQITTVIGTTGADGIATA
TLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNGAVADGAD
TNQVDALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGVASTLLTH
TVAGTSNVVATVDTVNANIDTAFVPGAVATITLTTPVNGAVADGANSNSV
QAVVSDSEGNAVAGAAVVFSSANATAQITTVIGTTGADGIATATLTNTVA
GTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNGAVADGADTNQVDAL
VEDANGNPITGAAVVFSSANGATILSSTMNTGVNGVASTFLTHTVAGTSN
VVATIGSVTENIDTAFVAGAVATITLTAPVNGAVADGVNTNSVQAVVSDS
DGNAVTGATVVFSSANATAQITTVIGTTGADGIATATLTNTVAGTSNVVA
TIDTVNANIDTTFVAGELENIVVSIINNNALANGADTNIVEAFVTDRFGN
GVANQSLIFGTNGASIVGSSTVTTNLDGRVRASATHTVAGSSNTVIAISG
AHQGYARVTFVADVSTAQLKLTSFLDNQLANGKAGNIAQALVTDAHDNLL
ANQSVSFALDNGAVIESQGDASSASGIVLMRFNNTLAGMTTVTATLDSTG
QTETLETHFVAGKAASIEMTMTKDNAVANNIDTNEVQVLVTDVDGNAING
AVVNLTSNSGMNITPNSVTTGSDGTATLTHTLAGSLPINARIDQVSKTIN
ATFIADASTAQIIAGDMFIIVNDQVANGQAVNAVQARVTDSYGNPIKDQT
VEFVLSNNGTIQYELDVTSVEGGVMVTFTNTLAGITNVTATVVSSGSSRN
IDTTFIADVTTAHIAASDLMVIVDDAVADNLDKNEVHARVTDAKGNVLSG
QTVIFTSGNGAAITTVNGISDGDGLTKATLTHTLAGTSVVTARVGNRVQS
KDTTFIADRTTATIRASDLTITRNNALADGVATNAARVIVTDANGNPVPS
MFVGYTSDNGALLTPTSGMTDSSGTFSTTFTHTTAGISKVTAAIVTMGIS
QTKDAVFIADRSTAHVSELIVVKNDSLANNSDRNIVQAHIKDAHGNVVTG
MNVNFSATENVTLTANTVTTNSQGYAENTLRHNAPVTSAVTATVATDLVG
LTEDVRFVAGAGARIELFRLNDGAVADGIQTNRVEARVYDVSDNLVPNSN
VVFSADNGGQLVQNDVQTDALGSAYVTVSNINTGVTKVTVTADGVSASTT
TTFIADRDTATLVTDRFLITHDNAVANGVVENRVLLHLVDANDNSVSGVE
VNFSATNGASINASAITDINGFAIGVLTNTLSGPSDVTVTLVTPGGTESL
TVTPQFIADINTANIATGDFVIIDDGAVANSVDANEVRARVTDNQGNAIA
GYSVVFSSQNGATITTSGITGVDGWASAKLTHIKAGESGILARLSRPMAT
VHTLMPYFIADVSTATLQLFNFNPIPIIADGVMQFFVLGRVFDANQNPVG
GQQVAFSATNEVTLTESNGSISTPEGSVLLSVTSTQAGVHPITGTLVSNN
YTDTFGAAFIANKNTAQLSTLMVVDNNALADGVTRNQVRAHVVDSTGNSV
ADMAVTFTANRGAQLSKVTVLTDNNGDAVNTLTNSLVGVTVVTAKLGTAG
TPLTVDTVFTAGPLATLTLVTTVNNAFADNSATNTVQATLKDVSGNPIVG
EVVAFAASNGATITATDGGVSNANGIVLATLTNGTAGVSTVTATIETLTE
TTDTTFIAMKNLDVTVNGTTFNGDAGFPTTGFVGATFKVNSGGDNSLYDW
SSSAPALVSVSGDGVVTFNAVFPTGTPTITISATPKGGGSPLSYSFRVNQ
WFINNNGATLNRADAITHCENVGYTMPTSTQVTNAATWMSGKRAVGNLWS
EWGDFSAYTAPGWVPAEFFWLSNNHDASTALAIGLSTGTLTTMGDFMAIT
HVMCTRPI
>YP3436 putative virG protein
MFMPFREFISSHVGRHPLFNRAPVAVINPITLAIIVAFSTLALPQTARAS
CNNSGGSTYICEGENNAGIILSGTDITVETQLGFGIIEPGDIDPALSLIG
SGAISYLDTNSSALDTAGAYSLSIQNDTSMIGQSTSTNVQANGSIGSGIY
ISSQSRDNSTIQVDLSGMLSSGLNGTPALSIDSLADNDSTIILNIHAISG
IAGIQSDNNSRYGTAITNVDIANDINVEYSGASIQNYSNSGTSILNLNSK
SISTDFDALDINNSNYSGEVMTDINIDGDISSANSQAARIYNHTNSGLSS
LRFRANNVTGEYAGLYIDNSSQNGAVTDIILTGDLTATSGSALYANTYSE
EGNVETAIKLNNVYSLYDALNIYGYNQTGNTLFDLDVSGTVTSENGTGIK
VMGTTFEGNSTILINVNNITSSSQSLDINNYNSSGSALSAITATGHLAAE
WGQGVTFQTYSSLGDATTLIHVNDITSMGNGIYSLTEASRGTVTTDVTVT
GQINVSDGEGITLNTQTIDGNTLVNIDVNNIASEYDAIHLYNNNNTTGVD
NGTGVDNGTSTIDLITRGALVSQQGYGINLETNTADTYVTVGGLVHGGNG
SAIGIHRLDNIQTSATLELQSGYALEGATQSLVFTGNYVDINDAALDLAN
SHLVLGGTGDAVFDLTRIDNREEAILDGDPNRITGFGTLTKTNSSIWTLT
GSNMADGDANAFLSANIAGGILVLDNATLGLTPATTILNRLSAADIAADP
TLVATETGALTLAEGGALSSLGDSVLSGNLISAGGILLSNTYTGGNGAAT
DDRLTVTGTYLGENNGSGEGAWLALDTVLGDDDSATDRLVINGDATGTTS
VRVNNAGGLGDKTLNGINLITVDGLAQDDTFLLAGDYVTTDGYQAVVAGA
YAYTLQADGEAATAGRNWYLSSELMLTEGVRYQVGVPLYEQYPQVLAALN
TLPTLQQRVGNRYGAPGALADLNFDDNQWAWGRIEGSHQVTDPARSTSGS
QREIDVWKLQTGIDVPLYQSQGGSLLTGGVNFTYGKAKADIHSFFGDGRI
NSAGYGLGTSLTWYGNNGVYVDGQLQTMWFDSDLSSRTAGHAVASGNNGR
GYTSAIEAGKGYALGNGLSLTPQMQVTYSRVDFDTFRDPFDSEVSLQEGD
SLRGRLGVSLDKETTWSAKDGTTRRSHIYSHLDLHNEFLNGSKVQVSGVE
FATRDERQSVGLGAGGTYEWQNGRYAVYGNVNLLGATRNVSDNYAVGGTI
GARVSW
>YP1205 putative exported protein
MNKEIKRMQRMQCIYIATWLIAVFTSPIVIANNTNINGSTNNNGNGTINI
FDASSNNDIHTLTGLGNEQLGGFSNHLIDSHNNTIDGGQSNNLVSSDGNM
ISAISLGDGLFYGAQNNTLINSNNNLLIVTQGSTIIDSDSNTVSGISNNL
IESNSNIIGNENSCYSDPASPSGAWCVDNQNTLIGSDNNTITGALNGLHN
SHNNDIIASSVNNLMDTHNNIIAGGHYNTISGGGNNDIFGSENNVTDSTD
ANINGSNNYVIDGNGIGRDDLTEDNSILGGSGNMGVGDSVTAITNSVVFG
GNTSGNSTGSTLTDSVSVSGNGTSGNNVVNIGGAANGNNSASLGTGSVSS
EGGIALGSGSIATRNDELNIGDRQITSVKKGVENTDTINVSQLNDSFDDV
LNLSNEYSDNSFSTVTENINNYTDASLDTVLNTTGEYTDNSILLVTNESN
NYTDNGMESVSNYANIYADESLLAIYNEEANYMSNLIDVTLNNANNYTDL
SVNTIIYTGKQYTDSRINEYQRTFKNEFLTYSNGKFGGFDKDINQKQKQL
NAGIAATMAAAVIPQKSGSKVSIGVGLAGYSDQGAGSVGAIWHVNQRITM
NTTMTYDTQRGVSLLTGLSIGI
>YP3004 putative membrane protein
MIYYVVALSGILLLVLNNLKWMKIKRSISNTKKSKAKSTSSITILIKKIF
FEWIDYVSTHSKSTPHILLPICSLVIVYYINSTWINVNYSFVFIINIIFI
IVLQLKYARSKHYLLFKQDFPEVLLMINMAASSGASINQVLERCGKEIRG
PLGQELGLICRRLNLGETPETVFYDAYERFHYPEFYFLVTIILLNIQQGG
QLKELITRLSQIITKKKTTEQKKAVMTAQIRMSVNIISIMPMLFSFLLYL
LDPTTIEFVWQHPTGRFIIYYIIISEVIGILIIRKMLGKSL
>YP2427 ccmD, putative heme exporter protein D
MTPAFHSWAEFFAMGNYAFYVWLAVAATLLSLLGLLMHTLWQHKQLLADI
HRRQAREQRIRQAQLNQTSMHQVPLHQAPLHQAPLQQAPQHIANLQEKRP
>YP0774 clpP, ATP-dependent Clp protease proteolytic subunit ClpP
MSYSGERDQFAPNMALVPMVVEQTSRGERSYDIFSRLLKERIIFLTGQVE
DHMANLITAQMLFLEAENPEKDIFLYINSPGGVITAGMSIYDTMQFIKPD
VSTICMGQACSMGAFLLTAGAKGKRFCLPNSRVMIHQPLGGFQGQATDIE
IHAKEILKVKSRMNELMAYHTGKSLEEIERDTERDRFLSAEQSVEYGLVD
SVFTRRD
>YP0075 cpxP, putative exported protein
MRKVTTLVMASMFVLGSSAAFAADNTKVTEGYHGDGKMMMNKKGDRGHHN
MFDGINLTEQQRQQMRDLMRQSHQSQPRLDLEDREAMHKLITADKFDEAA
VRAQAEKMSQNQIERHVEMAKVRNQMYNLLTPEQKEALNKKHQERIEKLQ
QKPAAQPSSAQK
>YP2935 cyaE, putative membrane protein
MMTHAVLTARIAKISLTCSILSWSLLIVGCATDRLDLAPASYTEPWTPDG
NARASMGGGNFSVPPNPIVAELAQPPTIKSDHAYSLPELIDIAQRQNPDT
RIAWQQARQAALAVGMGEAIFLPIISASVIGGYQRTTTPLPYAIGNEKDL
KTTGSAVIPALALQWLIFDFGQRSALLDAAKQTSYAANVTFNGMHQKLIY
DVTRTYFQYGAAQAQSQIAKQTLQNSLKIQDAAEERQKKGIATTVEVALA
RQQVAQSQLRRVVAKGTERDAYQALLGAMGVSPSLDIKAAYTEDRALPDG
ISAPTEKMIQLALSQRPDVLASYAAVEAAKAGIKATEADFLPKVYLAGAV
AGGDGHFDIQGLPGISPQTSSSSILVGVSVPLYDGGIRAARVKEAESRAA
VAAEGFKKTQELAVREIVVAADTLRSALESNQAALNLVKTSFISYDAALE
SYRSGVGTITVANEAANGLLNAQQMSTDAHAASLVAAANLAFVMGKMTNT
SPPLELLH
>YP1733 ecpD1, putative chaperone protein
MRRTLLTILSFLRTVRLLTTLTLLILSVVATVARAEVMISGTRVIYEEKQ
REGVVKVSNTGDMPVLLQAWIDKGDANARPEAIKVPFSVTPPVVRLDPKR
DQTIRLFRTDGGLAADRETLFWFNLLEVPPKPIQSAAGGENKMQLAFRTR
IKMFYRPEGLTVLPAQAAKSLAFSMKGNQIVIKNASPYYITLRKLELRTS
EKGPVLANFTKINNKMVAPFSELSLPTSAKASINNSAQVFYSVINDQGGE
TQGTQKLTQ
>YP2571 ecpD2, putative pili chaperone protein
MLFGSVMFSKIIILVLSLTISSIPAFAAMTISGTRVIFPAAEKEVSIRTN
NKGVQPALVQVWVDDGKTNANINSMKLPFMVTPPVFRVEPGKGQTVRMIY
NGMALPQNKESVFWFNMLEIPAVKKEGNTQNKLELAFRTRIKVFYRPTSL
ESNSAAQSAQLKWTLVDDNQKGRGVKVVNPTPYYISFDSGSITVGAKSVE
IITDMVPPFSEKMFFPKLKLLGSTSISKMNYKILNDYGAAIDEELSFSQG
QGVLVSKKK
>YP2997 exbB, TonB complex protein
MHIGWRRSVKIAGKESKEISRVQGRVMKGVMVLLLATGLAGHAQAAPGNG
SAVAATVTAPTAATSTPLPAPEITSVAAIPESTPESVLTSASALTSESIP
APMVQPVTAPVPQKLAMDLSVWGMYQNADVVVKGVMIGLVLASIVTWTIL
FSKGTELFRARRRLRQEHEVIGAVTDLDTASERAEDFGQGSVSSLLLHEA
LNERLLSIESNDNNGIKERTAFRLERRVAAIGRQMGKGNGFLATIGAISP
FVGLFGTVWGIMNSFIGIAHSQTTNLAVIAPGIAEALLATALGLVAAIPA
VVIYNIFARQIGNYRAQVGDVAAQVLLLLSRDLDLASSAEVKSPRHPHQL
RAG
>YP2998 exbD, ExbD/TolR-family transport protein
MAMRMNDSLDESGELHEINVTPFIDVMLVLLIIFMVAAPLATVDIKVDLP
ASSAVPQPRPEKPVFLTVKADNQLYVGDQPVDRETLATALDKVTQSNKET
TIFFQADKVVDYETLMSVMDALRKSGYLKVGLVGMEAGSSGAK
>YP0389 ffh, signal recognition particle protein
MFENLTDRLSRTLRNISGRGRLTEENIKETLREVRMALLEADVALPVVRD
FINRVKERAVGHEVNKSLTPGQEFVKIVKNELISAMGEVNNELNLAAQPP
AVVLMAGLQGAGKTTSVAKLGKFLKEKQKKKVLVVSADVYRPAAIKQLET
LAQGVGIDFFPSDAQEKPIDIVNRALQQAKLKFYDVLIVDTAGRLHVDEA
MMDEIKQVHAAIKPVETLFVVDAMTGQDAANTAKAFNEALPLTGVVLTKV
DGDARGGAALSIRHITGKPIKFLGVGEKSDALEPFHPDRIASRILGMGDV
LSLIEDIESKVDRAQAEKLATKLKKGDGFDLNDFLDQLKQMRNMGGMASM
LSKMPGAGQLPENVKSQMDDKVTVRMEAIINSMTLKERAKPEIIKGSRKR
RIATGSGVQVQDVNRLLKQFDEMQRMMKKMKNGGLAKMMRGMKGMMPPGF
PGR
>YP2305 fhaB1, putative hemolysin
MRPTMNKNLYRIIFNKVRGMMIVVADIAASGRASSSPSSGLGHTQHRRIS
ALSTLSFSLLLALGCVSLSVQAAIVADASAPGNQQPTIINSANGTPQVNI
QAPSSGGVSRNVYSQFDVDGRGVILNNGHGVNQTELGGFIDGNPWLARGE
ASIILNEVNSRDPSKLNGYIEVAGRKAQVVIANSAGITCEGCGFINANRV
TLTTGQAQLNNGQLTGYDVERGDIVIQGTGMDSSRQDHTDLIARSVKVNA
GIWANELSVTTGRNQVDAAHQNINAKAADGSPRPTVAVDVAHLGGMYAGK
IRLIGTESGVGVHNAGEIGASAGDITITADGMLMNSGQINSSQQLVVNTA
ADIENTGVLYAQGNTQLTTAGTLSNSGTLAAGGDTSVRAAEVNSTRNSVL
GAGVKSDNSAITSGTLSVEASGKITAQGKNISGTAQRFTAHRLDLSGSQT
QSRDITLIAQGGEIDLTGAELLASDRLSAATTALLRTDNASLIAEQITLD
AQALSNVGGLIAHTGTTDFNLNLPGDVDNRGGTLLSSGTLSLQAESLNSN
GNSLLGAGVQSDGRLTEIGDLRVTTRQDLIAHGQTLAAGAMALTGSRIDL
ADSYTQAREMTLTANRGDISTQRATVLALDTLSINTAQTLNNQGGTLAGN
TLALDLGQFDNQGGQVTASQDLTIDLQRDFSHQAGSTLQAGRDLTLTSLG
AVTNDGQLVAGGTLSTHSDSLLNSGNLIATQAELNATGALINHGEILTLG
GLDTDSNTLFNTGSIISAEATLNARERITNSGPDALIGATDENGTLALLA
PVIENSDTVTHTDTAPTTTILGMGTVILAGGHARDGHYASAAQVLNLSGL
IESGKDMLIYATTLTNSRHILTANTDFIVADTVTGTAVWTAENPDIPGGR
YAEPPDGGADNSDYIGTEYTSVIAYNGIDQSSPEAQLLAGGNLTPQVGTL
ENFWSKVSAQGEIDLTGVTLQQDGWGDQQRLMEQTTSSGVWRYRTYKGGL
WTREWGPEVSERATSEYASSFTAKTLSGSGTTINNGANPGAIAPPADRDN
SGKDLAVEFNGISLTQPNGGLYQFTTDHTVGGGGYLIETHPAFANLNNWR
GSDYVLQQLNNDPDVIFKRLGDNAYEQRLVRDQVLALTGQAVASDYRSAQ
EQFEALFAAGLEYSKAFNIALGTHLSAEQMAALTHNIVLMETRDVAGQTV
LVPVVYLAGVKPGDLQANGALIAAENISLTEVQGFTNAGAITATNDLKIS
MAQDITLNNRGGLLQAGGDMQLSTLNSDIDLTSARINATNLQLDSGRDVI
LRTDSAQLSSDNGAVSRDQTILGPLASINVSNNATINTGRDFIMQGASLN
VGQDLQVTTGGDWQLETVQTRDQISTHDGRGSATSEHIRHLGSEVNVGGA
LTANVDNLTAVGANINAATLEVQAQNISLSAATDSLHVTGESSSKRHTSS
VNLYDETLLGSQLNATGDINLQAAQDITLRASAVQTDGALTLAAGGDVLL
TTQTEQHDEQRNHTGLSKGIASSTLTRTEDSLSQTLAVGSMLSAGSIDVS
GKNIAVMGSNVVADQDISLRAQENITVGTAQQSESESHLFEQKKSGLMST
GGIGVTVGSSSTKMTDSGQSISSVGSTVGSVLGNVSMTAGEDLRVQGAEV
LAGKDINLTGKNVSILAAENQLTQSHTVEQKQSGLTLALSGAVGSAVNTA
VTTAKAASEESSGRLGALQGVKAALNGVQAVQAEGGDAASMFGISASLGS
QKSSSEQHQEQTHVTGSTLTAGNNLTINATGEGNAANSGDIVVQGSQLQA
GGDTTLDAARDVLLLGAANTQKTDGSNSSSGGSVGVSLGISGASSGLSIF
ANANKGQGSEHGDGTSWTETTLDSGGTLSLYSGRDTSLVGAQVSGETVKV
EVGRDLLLQSQQDSDNYDAKQQNSSVGGSFSPGSMTGSISINGSQDKLHS
NFDSVQEQTGIFAGSGGFDITVGGHTQLDGAVIGSTATADKNTLDTGTLG
FSDIDNQADFKVEHQSVGISTGGNIGSQFVGNMANGLLVGANNEGHADST
THAAVSEGTITVRDTDNQQQNVDDLSRDVEQANNALSPIFDKEKEQNRLK
EAQLIGEIGSQVGDVFRTQGQIIATQAATEKMQEVSEADREAAKANWEKA
NPGQIATAEDINGQVYKTAYDQAFNASGYGTGGKFQQAVQAATAALQGLA
GGDIAKAIAGGSAPYLAEVIKQSTGDNEEARLAAHAVVGSVLAHLQGNSA
VAGGAGALTGEIAADLIMQQLYPGKMVSELSETEKQTISALSTLAAGLAG
GLTGDSSADAVAGAQAGKNAVENNALGLALKGCGIAAPCRSLIAKQVLEI
GVKAGITGIVAKEIADKISEDDLDHLVTLKMMGNDEITEKYLNSLQDKYA
PAHTGGDQNAGSGPTDTGGNQIADNSPDHTGNDQSTGQGATNTGNTDGKP
DAGGNVLVNPGADPLTKKDIVYLSENPNGKIDTVINETLSGKKNFTSSTT
LTSDEALAAGLKFLGTGYKEIGKSGSGVYHSADGTKEFRIDSGSIDGAHA
PGVPHVHFGVKNPETGKYISNNHVPYKD
>YP2919 fhaB2, putative adhesin
MNKNLYRIVFNQARGMLMVVADIAASGRAASSPSSGVGHTQRRRVSALSP
LSFRLLIALGCISLSAQAAIVADGSAPGNQQPTIISSANGTPQVNIQTPS
SGGVSRNAYRQFDVDNRGVILNNGRGVNQTQIAGLVDGNPWLARGEASVI
LNEVNSRDPSQLNGYIEVAGRKAQVVIANPAGITCEGCGFINANRATLTT
GQAQLNNGQLTGYDVERGEIVIQGKGLDSRGQDHTDLIARSVKVNAGIWA
NELNITTGRNQVDAAHQNINTNAADGRHRPAVAVDVANLGGMYAGKIRLI
GTETGVGVHNAGEIGASAGDIVITADGMLVNRGQISSAQQLAVNTPSGIE
NSGVLYGKGNTQLTTAGKLSNSGTVAAAGDTLIRAAEVNSSRNSVLGAGI
KSDNSAITRGTLDIKARGQLTAQGKNISGTAQTFNANRIDLSGSQTQSGD
LTFTTEGGDIDLTGANLFANRRLSVSTPSLLRTDKANLFAEQIALDAQAL
ANVGGVITQTGLTDFNLNLPGDIDNRDGTLLTRGNFLLQAEHLTSNSQSL
LGAGIQSDGKLVPRGDLNVTTRHALIAQGKTLTAGTLALSGSRLDLTDSL
TQAKYMRLTATEGDIALTGATVMAANTLFADTRQILRSDKAYLTADQINL
TAYSLSNVEGRVVQKGSGDFRLDLPGYLDNRGGVLLTKGNLALQAERLTS
NSQSLLGAGIQADGSKASKGDLQANTTQALIAQGQNVAAGTMTLSGSRVD
LTGSQTHASNITITARDGDVTTREATLITPGTLSMTAVANPEQTLNNRGG
KLHADNIQLNLAKLENSNGEIAAATDLWLRLQSDFIHQAGARLTAGRDLL
FNSRGALINQYKLEAGRDMQLTALSIRNTSADRNTNADNSSLLAGRGLSL
STDSLFNRGAIYTTGVGQFTVNGNTENIGEIYTEQQLTFTATGNLANRGV
MQTRGEMQLSAQGDVNNSGMLYSAGDQMRLSIAGNLTNEGKLHVANGEMR
LLTEGNLDNRGSLYGAGNSDITTQGNAVNTGSVYTQGALQWLTKGSVRNS
ASIAALGDLQLRANDLLSDNQSLMAAGLKADGSRSDSGNLAVSTEQALIA
QGQNIAAGSLALAGSQIDLTGSQTQANAISLTAKSGDITLTSAVIKAATQ
LLVTQLAATRSSFIPPSSIPPSSTQSSSTQASASPSAWLRTDKASLIADQ
LTFDVQALSNLGGVIAQTGATDFNLNLPGYLDNRGGTILSKGNVAIQAQG
LDSDSGSLLGAGVQSDGKLTNAGDLAVTVRQDLIAHGQSLAAGAMTLTGS
GVDLTGSQTQARGITITANKGDVSTQRANILSLGSLAINAGANAGQTLNN
QGGSLQANNIALNLGQLDNRTGKIAASQDLVLGLQSDFNILADSTLQAGR
DFSFTTHGALTNDGQLLAGRKLSTRSNSLLNNGNIRAVQADLRASGALTN
RGEILTRGGLSTDANTLFNSGTLIGATATLNARERITNSGPNALIGATDK
NGTLALLAPVIENSDTVTRTDTAPTTTLLGMGKVILAGGQDNSGNYSSAA
QVLNLSGLIESGNDLLVYAKTLTNRRQILTATTDFIVGDTETGAAYWTAE
NPDIPGGRYTQPPAGGPMNSDYIGTNYTSTVAYNRIDQISPEAQLLAGGN
LTLQVGTLENNWSKVSAQGVIDLTGVTLQQDDWGSQQRLVEQTTSSGEYR
YRTYKGKLWGIAWGPEMKLRLNNQYASSITAKTLTGSGTVINNTVINNGA
APGAIVAPRDRDSTGKNIAVEFNGIALTLPRSGLYQLKTDKGDYAPGPEA
ALSLANISPPSSLDATGQRGVPPPSDDLNRTGLVTPDRAVSGGYLVETHP
AFASLNNWKGSDLYLQQLSSDPSVIHKRLGDNAYEQRLLRDQVLALTGRT
VASDYRSEQAQFEQLFAAGVQYSKAFNLAPGTRLSAEQMATLTGNIVLME
NRDVAGQTVLVPVVYLAGVKPGDLRANGALIAAENISLTEVQGFANAGAI
SASNNLQISMAKDITLNNRCGLLQAGNHLQLSTLNSDIDLTSARLNATNL
QLDSGRDVILRTASDQYSSGNGAVQRTQTILGPLASLNISNNAVITAQRD
FIQQGAGINIGKDLQVNTGGDWLLSTVQRSDQISAQYGGGSATSGSLRHL
GSEVKVGGALSANVDNLTAVGARVNAGTIDVRAQNITLSAATDSLSVTGG
SSSKRHTSSVNLYDETLLGSQLNATGDINLQTVNDITLSASAVQTDGALK
LAAGGDVTLTSQTEQHDEQRNHTGTKKGLLSSTTTRSEEGRSQTLAVGSM
LSAGSIDVSSQNIAVAGSSVVADKDIRLRAQENLTVSTAQQSESGSQLFE
QKKSGLMSTGGIGVFIGTSRQKTTDQTQTVSHVGSTVGSLTGNVRLEAGN
QLTLHGSDVVAGKDLALTGADVAISAAENSRSQQYTAESKQRGLTVALSG
PVGSAVNTAVTTAKAAREENTGRLAGLQGVKAALSGVQAVQAGQLVQAQG
GGITEMVGVSVSLGSQKSSSQQQQEQTQVSGSALTAGNNLSIKASGSDIL
IAGSQLKAGGDTRLDAARDVQLLGAANRQKTDGSNSSRGGSVGVSVGGSG
LSVFANANKGQGNERGDGTFWTETTVDSGGMFSLRSGRDTALTGAQVSAE
TVKADVGRNLTLQSQQDRDNYDAKQSRASGGISVPVAGGGAAVNLSMSRD
RLSSQYDSVQAQTGIFAGSGGVDIRVGEHTQLDGAVIASTAAADKNTLDT
GTLGFSDIKNKAVFTVEHQGGSLSTGGPVGSDLLSNLGGMVLAGLGNGGY
AEGTTQAAVSEGTITVRDTENQQQNVDDLSRDTGNANGSIGPIFDKEKEQ
NRLKEVQLIGEIGGQALDIASTQGKIIATHAANDKMKAVKPEDIAAAEKQ
WEKAHPGKAATAEDINQQIYQTAYNQAFNESGFGTGGPVQRGMQAATAAV
QGLAGGNMGAALTGASAPYLAGVIKQSTGDNPAANTMAHAVLGAVTAYAS
GNNALAGAAGAATAELMAPTIISALGWDKNTLTEGQKQAVSALSTLAAGL
AGGLTGDSTADALAGGQAGKNAVENNLLGGNEFTHTQFVQKHGADVLSCA
DNPSNAACQRGIAENKAYIAALATGSVALLPGSSQAMWALGAGTNAGMQY
ADNGKINPVNSVAAGWINVITMGQGWKGTIAWNAAGGALINAINGGDPLT
GAITNGTGAGFGYGVGNYVVKPAANTLGKWITGGWNPKFDPNLLKYAEVK
GQLGISKEMLPSKIPSAVGNAGGSLSSEFGSSLIQQKKDAMEDSK
>YP2923 fhaB3, Putative hemagglutinin/hemolysin
MRRTYKGKLWGIAWGPEMKLRPNNQYASSITAKTLTGSGTVINNTVINNG
TAPGAIVAPRDRDSTGKNIAVEFNGIALTLPRSGLYQLKTDKGDYAPGPE
AALSLANISPPSSLDATGQRGVPPPSDDLNRTGLVTPDRAVSGGYLVETH
PAFASLNNWKGSDLYLQQLSSDPSVIHKRLGDNAYEQRLLRDQVLALTGR
TVASDYRSEQAQFEQLFAAGVQYRKAFNLAPGTRLSAEQMATLTGNIVLM
E
>YP3368 fhaB4, putative exported protein
MKLTYIKTKQGLSILPLSIILSLYGSSVAYADNIIPDIQAPAGQQAEVSI
IETPPSTCRALTSYCIGMTETVVNIQAPDENGLSHNKYSKFDVVANGLFD
VTTLNNRLAQEVNGNSFLQDKSATIILNEVNSSHASLLDGNLRVDGGNAH
IIIANPAGINCRGCSFTNASHVTLTTGTPSFSDNKLNSFIVEQGNINIEK
NPSYYMRTGLRYKGADKTYLDLFADTITVSGEINADDGYIVTGKNKVGFS
LPGQPLQVSRLGNENTPVPGTVSLDVSEIGGMYTNKIRIHATDGTIKNKG
AIRANDTLSLSSAANIDNSNGNISGKMVLLSSEGVINNSGGTILNNGEYD
LLPSQGIKITSRGLNNEGGKIEYKNGSVEIATVNTIKNGKGTIKATSTQG
RVRIKLHSNNLNNTGGSIISSGKIEGKVNNIRNNGGAIIGLGGVDLNETV
LINDTGKIISDFN
>YP1887 fhaC1, putative hemolysin activator protein
MNIFFRKKYMIILLLSNAVLATENNKNRLNDNVVSHADIDVRNEYNEEGN
RVGKRFFSTNHHSVASQKKISPEKICLPITGVFLQGNTLLSSQDLNQIDH
ILGECISEDDINILAKEVTRLYLSKGYLAARVNFIPLNNAGELGLNVTEG
IVEKIEGGGRRVNPYFIFPNFIDKPLRLSELDQAIDQANRLRSNKVNVDI
LPGSQAGKSIIRINNVNNKPWSLSTVIDNYGYKNSDEWQARVSLALDSPF
GLSDSINFNANRTLENAKNRYKNDFTVSYSVPYGALTFSALANYLEYRRY
EKLKNGTVNFNGNSQQYNFRTDYMFHRTQKQINSLSMQVEHKQINNYVDE
AKVGVYSYRFTNLELGVNQFRILPHGSVNVNAAIKRGVPWFGTHQKNKIN
AVQFTTGKLMVNFNHNFSLLNSPYQFDHALVGQYSKNYAPSPEWISLTER
NAIRGFSRSSQSADHGWYMKNTLSKHFFMGNILFTPRMGVDGGRALKHGS
QQGWQSNAGVSAGISMRYHQALFDVEASRGWWLSDSNKQNEPVQVLGRIA
YTF
>YP2306 fhaC2, putative hemolysin activator protein
MRYCYFILHTAILFPLLVISRAGQSAELTPIQQQTLHQQERQRALEERLA
PPTPDVRLSAPSASSDRLIFPVEKPCFVIDRVTLSGTEPLPRWLPLQRIA
NQALGQCLGGQGINQLMSQLQNRLVGHGYVTTRVLAPQQDLNSGTLALQV
VPGKIHRVALTPESDRHVTLFSAFPARPGHLLDLRDIEQGLENLQRIPTV
QASMELIPGSAPGETDIALSWKQSKMWRLAASLDDSGTRSTGRYQGGATL
FLDNPFSLSDQFYVSAGGSIKNRGDKGTNNLTGHYSLPFGYWTAGITASS
YDYHQTVAGLNSDYNYRGESENVSLQLSRLLHRNASQKTTLTYDVLTRSS
KNYINDTEVEVQRRRTSAWRIGLQHRHFISQATLDAGVSYQRGTRWFGAV
PAQEEYFDEGTALSKILQLNAQLDIPFSVMAQNFHYNVQYQRQSSSTPLT
PQDQFSIGGRWSVRGFNGERTLSADRGWTVRNDLGWYTPIQGQEIYVGLD
YGEVGGRGSAYLLGNHLAGAAVGIRGNVLNTRYDLFAGKPLSEPDGFQSD
AVTVGFNLNWQY
>YP2918 fhaC3, putative hemolysin activator protein
MSRFYYSILVAGVLLKIVAIPDASYGAELAPVQQSIHQQERQRALEERLA
PPTPDVRLSAPSAFFSRIIFPLETPCFVINRIKISGAEPLPRWLPLQRIA
DQAQGQCLGAKGINLLMSQMQNRLVDHGYVTTRVLAPQQDLNSGTLALNV
VPGKIRGVELTPDSNRYVTLFSAFPARAGTLLDLRDIEQGLENLQRVPTV
QANMVLIPGSAPGETDIILNWQQRKMWRLAASLDDSGTRSTGRYQGGATL
FLDNPLSLSDLFYVSAGGALQRRGDKGTNNLTGHYSLPFGYWTAGMTASR
YDYYQAVAGLNGDINYRGESENVAFQLSRLLHRNASQKTTFTYDVLTRSS
KNYINDTEVEVQRRRTSAWRIGLQHRHFISQAILDAGISYQRGTRWFGAI
PAQEEYFGEATALSKILRLNAQLDIPFVVMAQNLHYNLQYQRQSTNTPLT
PQDQFSIGGRWSVRGFNGERTLIADRGWWVRNDIGWYLPLPGHELYVGVD
YGEVGGRSGAYLLGRHLAGSAVGVRGNVLNTRYDLFAGKPLSKPNGFKTD
SLAVGFNLNWLY
>YP3367 fhaC4, putative hemolysin activator protein
MIFKINVRWRDKIGDFWWGILCLLYLQIMIGMLPFKVFAEMALPEMDLLE
MDIAEPQIPNSIIPPLSHAQLASEPVLPENLYNDEVQCVAINNVELINLD
AFPNAAHLKEKAEEAHGRCLGEQGLSVLVANLQQQLVVDGYITSRVVFVD
DSERDGTLMLKLMPGRIEDIRHHQDSVGNAHLSSLFPGKRGDLVNLRHLE
QGLENLQRLPSVNATLDVELNRDDLSSQIIVNRQQSRLWRINAYLDDAGH
DAVGRYRTGLILSFDNPLSRYNPLSLSDLLYFSVNRDLDSQPDKGHNSYG
VHYSVPYGNWLFSMTGNQGERYQSFSFAGKRLAGKKFGYRSHWSVLDTQI
QHLLTRGVNYKTVGYAGVLIRQSASFWTHREIDIQRFNTTDWQLGIEHLH
YMPWATFRGGVRYQQGASWFGAQPIPGKMSTAPARLVDITSSLDIPFKIG
TQSFQYRPAFSQQHTYSDISSLDKFTIGGRSSVRGFNENNALTGSRGWSL
KNDISWISPIPGQTFVGQQFYIGMDYGEVSEQGQPFLLGERLAGAVVGTR
GNYHAFGYDFNVGVPITKPAEFDADPLVFGFTLTWQY
>YP1665 fimA1, fimbrial protein
MKKTLVTLMLFILPGIAFAETSNNTIKFQGEVAEQTCMVDINGTANTPVV
LLPTVSTSNLNQVNSVAGKTNFTINLTGCNIAIQDTQISSVFQGMNVTSG
GNLGNIGTARNVAIQLIDPRGTPIRMSGGSVEVPGITLATGATSASQDLS
AQYITEEGQATAGSVIASAQYAITYP
>YP1732 fimA2, putative fimbrial protein
MKIKSSNVLIAAFAGLFIAQSAFAADGTITINGKITDTTCGISVNNGTKD
GTVTLPVVSASALDGINSVAGTTPFNIVLTGCTGATMGNAYAHFEQGTTV
EASTGRLNNSDIDGATGVQVRLLDKNSAPIVVGSGNQGNVVEDISGDGAT
LSYYAQYYANEANVEAGLVATNVDYTIVYD
>YP1735 fimA3, putative fimbrial componenet
MQMSAYFYRVKTVIRHINMYLRVYAHVRSVATLLILVVVAGGPSSKVWAE
GLGINCDYTGSIYINPPTSIIRVKPNAAIGDPIGSWMTISAPEVWSCALL
PAYQSRDVRAGILVFSPYNPLLTTNIDGGNYKVFRTGDTNPGLGIAVRFR
AIGAGFSSDWTQLEGFGLVDGTVSAPLIGPIPYNDGIKFPLGMEMQIHYV
KASEELRSGGVRIFDFAYLYHRRSIDGVPDNSGARYRIVQVPANSIDIQI
MTQTCTTPDVVVNLPEVNSRQFTGIGTVKALKAFNLNFNHCPGGLDGINY
KFGATTSILDSANGVVALDANSTAEGVGVLLRSQSDAAIELDKEYTMSGY
DTSSTQSYTVPMQAGIYQIENTVTPGSVKGEFTFTLIYK
>YP2572 fimA4, putative fimbrial protein
MNAMRKLNLAVCAVALSVISSTSYAAAGGTVTFNGKLIADTCQVDTASEN
ITVTLPTLSIQSLAVAEAQDGSKDFEIKVLDCPATLTQVGAHFNAIDSSG
VNPATGNLVNKAPTDAAGNVEVRLYNVDDSSQIRVGSTGNMVNIVKVGAT
PGTANLTYAGGYYATDATTPGEVNAKVEYVLAYN
>YP2756 fimA5, putative fimbrial protein
MSSSLKNKVAQKPIALLLLLTTVFIAQSQPAQAASSCAGTADCHIQVSFG
GEYVEDTCEVSINGASSAESVSLPTLSTSKLNIDGAEAGNQAFQIALKLC
PANRSVDLRFTAADSSRNPDVITGNLQNELADDYSRNVQVRLSKATGQQM
FVGRENSVQEYVIPATGEDITHYFLAGYYAKGTNAVTPGQVKATAGIELV
YK
>YP3169 fimA6, putative fimbrial protein
MKKITLAIALFSASTTVAMSASNNTITFQGEVTAQTCSVTVNGLEANPVV
LLPTVSSSDLDASGQTKGKTTFTLGVSGCTSGSDDLDIKTVFIGSLVTAT
GNLQNTGTAGNVELQLLKDATTTTGIDLNSGLAQDGIVLLAGDTSAEHDF
AVQYYATGQSTPGSVIASVQYAVSYL
>YP3406 fimA7, fimbrial protein
MYSLLIILLCDWYFRDISFKCNIYIKVFNMSNVKKSTFIIALATLSVIYQ
ALAADAGNGRIKFTGTVINAPCSIALDSTDINVDLGQVANRVLETGNKYS
QSVRYNINLQDCSLTAQGSGGATYPALSKVNVTFSGIADAAAPALLANTG
SAKGVGVRLIGTDDALLKVGDTSPDINLTSGPNQIVFSARIEATSAPVTT
GTVVSQATYALNYK
>YP0460 fimC1, putative fimbrial chaperone
MQNFPTHHRDIGATIIYVNSVNRFNIFFVFTLLILLSSWSAVSYASFKLE
STTVILQESEARTSFTIDNISSNPILLVTKLTDLDGKSFSKQILISPPVT
RINAGQSQQVNFVLKKGSVLNNEVLLKASFEGVEQVPGNAAVMPIRQEIG
FLIQPSAVPQIRMPWQTLVFSISGNNLVIKNPGKHVVRLGPQIILVPSNE
VVALGNPYIMPETSKLFPITSSPTAVKVTPLSRYGFVQTEVTLPVTR
>YP3403 fimC10, putative fimbrial chaperone
MLIETELFTAKCGLLQWNSEMKDINSMIWRQQRLWAKTALFGIALWLTAL
TSQAAINLDRTRIIFNSTDKSASVILQNQSPSSPYLAQSWLENTKGQKIE
SPLVALPPMQRIDAGQKSQVRIMKLPDADKLPTDRETLFYFNVREIPPQS
EMNNVVQIAIQNRIKLFYRPMAIKANYSDIWQEKLQISKLVGGLKINNPT
PYYITLAYLSQNEQGNFPGFDSVMIAPFGTEFVKTPGYSGSRYNVGYMDD
FGGIVIRTFNCLSAECQIQPAEKRR
>YP1661 fimC2, probable pili assembly chaperone
MRLLSLFLLLFTISYDALAGLIAGSTRIIYQPELRERTLMLANTNDYPVV
VQTWIDNGDVDSTPDQAKAPFMVLPAVFKMQAGSVQALRIINKGENLPSD
RESVYWLNLYEIPPRERSNIDVHAQVAMAMNTQMKIFYRPNGLAPPPIDA
MGKIKFSLKNIDNQYVIIANNPTPYFVSFGQIQLQSQQKNYLIAQSMDMM
TGPFSTRPYYFEQPPTSLKGKFTVSYIYFDDAGNQVKNSQSVTVTL
>YP1664 fimC3, probable pili assembly chaperone
MILIARQIIACSMLLLTSVSLSVQASVVMTGTRIIYPEGSREKVLQLSNK
DDHPNLVQLWMDDGNNQSSPSKSDVPFALTPQIFRMEANSGQVVRLTYIA
RNLPKNRESVFYLNFLQIPALKADTLGEKISVTLDTTTGNKIKVHNPTGY
YISLRDAKIVSNGKTVSFATSEMFAPDSTTDLALPIGIKAKKGELLILNV
VNDYGATIPNNYYL
>YP1722 fimC4, putative chaperone protein
MIKYHLLSKLILSFILLPIAPLHAAVSVLIWPIDPVINDDENATALWLEN
KDSQPTYMQIRVLSWRQVNGLDDYNAQTAIIASPPVANIQPGKRQLIRLV
KNAQVPAGKELAYRILIDEIPRQEPNDKNNPSSTQLGLTFQMRYSVPLFV
YGNGMQIAPEATQPTDIAQPTLSYILNRQQGKQWLTIRNQSEIHARISQV
TLNGQTVNNGLLGYVLARSQMSFPISLAARKGELAAIINSNTKPVTIPYQ
>YP1736 fimC5, putative chaperone protein
MKTLWLILRPRARKVNNLRTLLITAILSSLVLSATVQAGVAIGLTRVIVT
GADKSGSVQILNDGLHPALLQLWVDNNIAEMDKPIEQINVPFVVDSPVFR
LNAKTNKSIRIYYTGGANQLPSDRESMFWLNVLEVPPKASANQSSQNAVQ
IAFRSRIKLFYRPAGIPISSEGVATKLSFTLVPKGEGRVLRVANPTPFNV
TFQTLAIAQSHTAQGVTIKLGADDMVGPKSSVDSAPVGNNALAKNMSVFF
TIIDDFGSPIEGQQPLQ
>YP3012 fimC6, fimbrial chaperone protein
MKKLSLIALTSTVVFTSYTANAAIALDRTRIIYNGQDKSISLNISNENKT
LPYLAQAWIENEQQQKVTTPLVATPPVQRVEAGKKSAVRISATPEALKLP
QDRESLFYFNLREIPPRSEKSNVMQIALQTKIKLFYRPEGITPATGQIWQ
EQLVLHKTAQGFRLENPTPYYITVVGLAEKGKSSADSNFQPLMVAPKSSA
ELKSASFTAPVLTYINDYGGRPELSFSCSGSTCRAAKAI
>YP3165 fimC7, putative pilus chaperone, PapD family
MHMRKWLSVSNNIMLSRINRRLRGLLLLMTTCRVLTLPALTIGVLIMSAL
ATSAVASVIAERTRIVFSEGSTEESLQLVNSNSYPVAVQVWVDDGNLMAT
PDKAVSPILVLPPVFRLQPQAQRSLRLILSGGSKLPADRESAFWLNIYEI
PPKATPKSGDESFVTLALRMQYKVFYRPKNLPAPGDILGKALTFSLERNG
DSALIKVNNPTPYYASFAALTIGSAEGPPEMVAPFSQLDFPLNRAPISDN
KTVNFDLIDDLGNRNSFSHELK
>YP3168 fimC8, putative fimbrial chaperone
MLSIYARHYHYLFVTLLVAMSLSFANASVVMTGSRIIYPAAASEHSIQLT
NNDNFPNAVQVWLDSGDEKSTPETGKAPFIVTPPFFRIEANSGQTLRLKY
TGSGLPTDRESVFYLNFLQIPPVNKVEKDNKMLVLLRNRIKVFYRPESII
GRVDQVSTALTFSLRKQGTNLVLTGKNPTGFYATIASGEIVSGSIKLKVK
SNMIAPMSQVEWVIPNASVSSSATINFLIMNDFGGQDAGSYRI
>YP0459 fimD1, putative outer membrane fimbrial usher protein
MVARCINLQCIAFLFSFFPTLAFPVTEEGEVVFDIETLERLGYSAELAKF
FSGQDRFLPGQHDVTIIINASKTYRIAATFDSEGKLCMDKALLMALKLRN
TESDGSCENMEARWPGMVVKLFPGQFRVEITLPQEAFDPEMEGSEYQQGG
HALLLNYNIFGQRVESNNSRFNLVQGQFEPGINFKNWVLINRGSYSYNQG
VSQYYNQETSALRAVESLKSVVQLGEFGLVGNTFSGLPVTGIQLYSDNAQ
RDDTQLIVPIEGIANTNATIEIRQRGRVIYRTIVAPGPFSLSNISNFSSG
VNTDVSIIEEDGTQQNFTVTSALDINAEQQASIYQLAVGRYRDMFTGEDR
PSPLLLSGEMSFNPAATFYMTSAGLLSSGYQNIRVQNLYSGWDQAWFSAA
ASYANTKDAGQGYQFSVQNQMTINGNFGVSWSSVYGSANYWLPDDALSSS
NNLNDLMFGKLKNATSVAVSWVHPRWGAFSYALSNNMYYQASGRTYHIFS
ISEQFGRATTILSSQLSSQGQNSLYVGINMPLGNGTLSGRVQRNNGNVAL
GSTYQGRWGDNKDYSVGISGDNRQRRINGSMNIRTAYSQLTGGVSQATNN
SRSAYLSSRGSVAYVNNTFATSSSSVGDTFAVVNIPNQPGLRVSSPSSGI
AITDYAGIALLPLVRPYTASKVQISTQTLPLNIRLNNTSADLLMTRGSVA
THHFETTETRQLLLTIRGSDGEMLPIGANVLDEKGNFLGTIIGDGNFMLE
NKAIGVTLRVKANNRDECRVNYREPEKFDPDVLYEVADAVCQ
>YP1663 fimD2, probable fimbrial usher protein
MRIAPWLSCLLTQSLLVTHISSAADNNNQDDYIFDDALVRGSSLGLGSIA
RFNKKNSYDAGQYQVDMYMNNKFVDRLKMLFVDKDNSVEPCLSVAQLLQA
GVKEEALKTADPKTPCLAFQSILPASDFRFDHAKLRFDLSIPQKFVKNVP
RGYVDPKNLTAGNTIGFSNYNLNQYHVDYNKEGIKRTTNSTYLSLNSGIN
IGMWRFRQQGSLRYDASRGTNWTSNRLYSQRALPTIGSEITLGETFSSGQ
FFSSLGFLGVALSTDDRMLPESQRGYAPVVRGIARTNARVMVYQNNRSIY
QTTVSPGAFEFNDLSVTHFGGDLTVEINEADGSVSTFQVPFASVPESLRP
GYSRYSFAAGQVRDVGNNETFSELTYQQGISNAITANTGIRLASGYQAIM
LGGVFTHYIGALGLNTTYSHARLPDGEQQQGWMAKASFSRTFQPTNTTLS
VAGYRYSTDGYRDLSDVLGVRATSNDSSWNSSTYRQRSRAEISLNQNFHR
YGSLYLTASSQDYRDDRSRDSQLQLGYSNTFWRNTSFNLAISQQKTGGAN
KIYFVDPGSGMPASNGANTLATRETVAQMSISFPLGGSSSAPYVSAGAVN
SRTSGASYQTSLSGTMGSDQTAGYSVDVARNEPTNENTLSGSLQKQLPTT
SLSGSASRSPGYWQGSASARGSVAFHRGGVTLGPYLSDTFALIEAKGASG
AKVMYGQGARIDRFGYALVPTLTPYRYNTLSLDPDGMDFNTELQDGERQI
APYAGSTVKVTFRTLNGYPALITIKMPDGSQLPMGTVVYNYNGKGTNDKN
DIVGMVGQSSQAYLRAEELSGTLTLVWGESSKERCQLDYDLGKPTDNDKQ
LYKLDALCVAVQQ
>YP1721 fimD3, probable outer membrane usher protein
MIIRFRLPPLSVLIYGSILLPSLIPLTILGGSLPPPSTSTTMPDTTLYLE
LVVNDRNFGSTVPISYRNNRYYLSQSQLRTIGLPISEPLAPEIAIDNMAG
VNVKYDGENQRLLINVPSEWLPKQQIEVTEQDDFNLAQSSLGALFNYDIY
ATQGYPYSSLTHFSAWTEQRIFDRFGLLSNTGVYRTHFPSNNNTDDAKGY
IRFDTQWQKNDEEHLLRYSTGDLITGALPWSSAIRLGGIQIARHFAIRPD
LITYPLPQFSGQAAVPSTVDLYIDNFRTQSANINPGPFVINNAPRINGAG
QATIVTTDALGRQISTSVPFYVASTLLKPGVWDFSLSGGALRRNYAIRSA
DYGEMVASGVVRYGTTPWLTLEGRGDIAKEMHVIGGGVNFRMGLLGVLNS
AYSISNTSNGAFNNVAEPLNTNNATPNRLPSPAASRRGRGNQRSLGYSYS
NAFFNLNAQHIISSDEYSDLANYKTPSLLSRRMTQLTGSLSLGSYGTVGS
GYFDVRDALGEQTRLINISYSTSLLRNSNFYSALNRELGRKGYNVQLVWS
IPLGPRGSSSISATRTNDNQWIQQLNYSRSAPSNGGLGWNLAYANSTNNN
NQYQQADIVWRTSMMESRMGLYGNSNNYNYWGGLTGSLVVMNRSVYASNM
INDAFALVSTNGFSNIPVSYENQLIGTTNAKGYLLIPTVASYYQAKFQID
PMNLPADVMLPNVERRLAIGERSGYLINFPIKRISAVNIRITDASGQDLP
KGSAIYTTGNIPISYVGWDGMVYIEQVAQLNNLRIIRADNGTQCYSQFKL
KTTEGIQDAGTTVCR
>YP1734 fimD4, putative outer membrane usher protein
MLSAFIFFQKNECLKYLPAFSFAICGIGGMLYIPSSAAENSEYVEFSDAF
LRFPVDATRYSEGNPVSPGERQVDIYLNDQWIGRQEMRFALPSPESKVAT
PCFDVKLFDELGVDTAKLSSDTVKLLESRGACSPLSRLLEGGNAIFDDNQ
QRLDIQVPQAYLIRQARGYVHPKYWDDGVTAATLKYDYTGYRSNQNDIGS
QTYQYLGLLGGLNWQSWRLYYRSALNRSDSQGFDYQNLATYVERAVPSLY
SKMTIGDSNTDGQVFDSLSYRGIELTSDDRMYADSQRGYAPVVRGVARTN
ARVVVRQQGRPIYETTVPPGPFVIDDLYPTGQGGNLNVTITEADGSEQTF
IVPFASIAELLRPGTTRYSLMAGEYRDNSMVDKPVLFMGTVRHGLSNLLT
GNGGMVAAEGYLSASAGLAFNTPVGAVAFNVTQAQTRLPNKDNQRGQSIG
MTYAKSLPETNTNLTIASYHYSSNGFYTPAEAMRMRDYLQHGEVNNTQID
SSWPNGSDRYDDSFKYRRRNQAQVSIAQGLPDGYGSFYANANVQDYWDGR
NRDMNFQFGYTNSYKSLSYNVALNRLRDIPSGDWDNQLSVSLSIPLGTHA
GAPRLSSSYSNTRGSSAIQTGVSGSAGEDNQFSYGVSAANNRSDENGSYN
TLGANGSWQAPYATVGGSYSKSNSYDQASASLSGGVVAYRGGVILAPALG
DTVGIIEAPDAAGARVGSYSSMYLDRRGRAILPYLSPYRQNEVELDPKGL
SADVEFKSTSQKVAPTAGAVALVTFETSTGYSVLVRGHLADNTPLPFGAE
VKDGGGTRVGFIAQGGQAMVRVNQQAGNLRVIWGDGIGESCSFDYKLPEG
NLVKGHLVKGDYRRLEVICK
>YP3167 fimD5, putative outer membrane usher protein
MVQARVILKKNFSGRRKALTLCITLILHIDTAFGQEEPQNFEFDESLFLG
TKYASGLTQLNKKNSITAGNYDAVDVLVNNKLFKRMSVQFIKDANSSEVY
PCLSDELLTAAGVELGRENSTPPKEPHVTEANTPITETHAPTNQCLPLST
RVKGASFRFDQAKLRLELSIPQALLQKRPRGYIERAEWQEGEKLAFINYS
ANAYRSDTRGQQKRTSDFGFIGLKSGINLGLWQVRQQSNVRYASNDSGSD
TQWNSIRTYVQRPIPQLDSQLTLGETFTDSTLFGSMSFLGAKMATDQRMW
PVSMRGFSPEVRGVASTNARVIIRQNGREIYETNVAPGPFVINDLFSTSS
QGDLNVEVIEANGSRSTFTVPFSAVPDSMRPGVSRYNAVIGESRDFTNID
NYFTDFTYERGLTNQLTANSGVRLAKDYTALLAGGVLGTPVGALGLNATY
SHAKVENDKTQDGWRMQATYSQTFNQTGTTFSLAGYRYSTKGYRDLNDVF
GVRSMQKNGGTWDSSTYKQRSQFTTTINQDLGNWGQLYASASTSDYYNDT
ARDTQLQLGYSNSYQQISYNLAVSRQRSVYTSTLYNWDSPDTDETATTTR
YGNTENIATFTVSIPLNIGSNNQYLSMSASRNPKSGNNYQTSLSGTAGER
NSFNYALNAGYDDSNFGSSSNNWGANVQKQFPNATVNGSYSRGNNYTQYG
AGARGAAVIHRQGVTLGPYLGETFGLIEANGAQGARIDSNGFALVPALTP
YNYNTIGLDTKGINRNTELKENQGRVVPYAGAAVKVKFETLTGYAVLIQA
EGEGLPLGADVYNSKDELVGMVGQGNQIYARIADNKGTLDVRWGESSGDQ
CQLPYAFNRQDTEQDIIHITASCRR
>YP3404 fimD6, putative outer membrane usher protein
MFRGGYQHSSPYGEFGLDGSHKNNEYNSINTNWYGSITATAYGVAAHQNK
AGNEPRIMVDTGDVAGVSLNNNSAVTNRFGVAVVSGATSYQQSDIRVDVQ
NLPDDIEVYNTVIQKTLTEGAIGYREIRAVKGRQMMAIIRLKDGSSPPLG
ASVITDKTGAEVGIVGDDGLTYLAGLQDTERLTVQWGKKQCTLILPKDKG
MNSGKVLLPCQ
>YP3405 fimD7, putative membrane protein
MPYNSKRKKTIFLMVKVLTIILVWLFLPESTAVVKFNTNIIDAKDRSNID
LSRFEVDDYTPPGNYLLDILIDDRLLPERYLVTYLAVDEGKSTKLCLTPD
LVNLFGLSTEVRESMTLWNNDKCVAIDEKKEIKIQYDKEKQSLIISIPQA
WLAYNDPNWVPPSQWGNGVAGTLLDYNLFGYHYSPNMGGSTTNFSSYGTT
GANMGPWRIRADYQYINTETAGEHYRNFDWSQVYAFRAIPSIGAKFVGGQ
TYLNSSIFDSFRFLGTSLSSDERMLPPTLRGYAPQVMGIAHTNARVVLSQ
NGRVLYQTNVAPGPFVIQDISEAVQGNIDVRVEEEDGRVTVFQVNAASVP
FLTRKGAVRYKAALGRPMLGNSASNPTFFSGEFSWGAFNHVSLYGGLMTT
SQDYTSAALGIGQNLYDFGALSIDITHSRAQLPNEEQQNGESYRVNYSKR
FEQTDSQISFAGYRFSKKNFMSMSQYLDWLNGNTALQYDKQAYTVAANQY
LAWPDITMYLSVTRRTYWNAASSNNYSLSMSKIFDIGTFKGISATISANK
VNNQYANENQMFFSLSVPIGIGQQASYDAQRGRNTGYTQNISFQQPESEK
YLAYQRGWR
>YP3704 fkpB, FKBP-type peptidyl-prolyl cis-trans isomerase
MNKPICSTGLRWLWLAVVVVILDISSKQWVMAHFALYESVPLIPFFNLTY
AQNFGAAFSFLADKSGWQRWFFAGIAIGISVVLMVMMYRSTAKQRLINCA
YALIIGGALGNLYDRLVHGAVNDFLDFYINNWHFPTFNLADVAICIGAAL
VIFEGFLSPVEKNAVNNDE
>YP1596 flgM, negative regulator of flagellin synthesis
MSSIDRTQPLSPVTQVQARESHDVAQQTRQSATQTKTPVSGTEVKLSDAQ
AKLMQPGSQDINVERVETLKQAIRSGQLTMDTGKIADALLKNVADELKNH
>YP1597 flgN1, flagella synthesis protein FlgN
MVVESLQTNLDQQLDLLESLTNVVAQEQQLLCSGRIQGWVLQGVTEQKSS
ILATLAYLDQTRITTETTANIQAPYTRMPALAERWQRLLQLTERLRYSNL
HNGLLLQQHIEHNNQALAVLNTRHGQSLYGPDGQAKGANILGRKIGI
>YP0420 flhA1, putative type III secretion system component
MFMSKSALVRGLTMITARQDIFLAVMLLVAVFMMILPLPTTMVDLLIAIN
LAFSVILLMISIYLRDPLEFSVFPSLLLITTLYRLALTISTTRLVLLQHD
AGEIVEAFGQFVVGGNLAVGMIIFTIITVVQFIVITKGSERVAEVSARFS
LDGMPGKQMSIDGDMRAGAIDSVEAKRLRERVQKESRLFGAMDGAMKFVK
GDAIAGIIVILINIIGGITIGVMQHKMSAEEAMNTYAVLSIGDGLCAQIP
SLLISITAGIIVTRVPGSNKQSLANELAVQVGRQPDALWLAAAILTVFAL
LPGFPFLIFITLAAAVAAPAFLLYRKNRRISQDGRANGGSEEGGATGQRM
TPGAVPLMLHCASNLHHPHLGRDIDGLRWRWFEHLGVPLPEVEIRCDPTL
AENTLSVQVYQERVLEVVLPPDSLLLTRPCSSLVTNNQVLGAKMGSFDWL
DAKQAMQARTLGIPYVEGHQRIITCLTRVFERYTAEFIGVQETRYLMDAM
EGRYGELVKELQRQIPVGKVAEILQRLVEENISIRDLRTIFGALVVWAPK
EKDIVMLTEYVRIALRRHLCRRFSHNKTWISVLRLGDGVEHLIRDSIRQT
SSGTYSALEERQSLLILNKIKNAFAENQDAVLLTTLDVRRFVRKIIERDL
FVLPVLSWQELGDEMNLKVAGTIELIGDELDETA
>YP1601 flhA2, flagellar biosynthesis protein FlhA
MANLAALLRLPGNFKDTQWQILAGPILILMILSMMILPLPPFALDLLFTF
NIALSIMVLLVAMFTQRTLDFAAFPTILLFSTLLRLSLNVASTRIILMDG
HTGGAAAGRVVEAFGHFLVGGNFAIGIVVFVILVVINFMVITKGAGRIAE
VGARFVLDGMPGKQMAIDADLNAGLIGEDEAKKRRSDVTQEADFYGSMDG
ASKFVRGDAVAGLLIMVINVVGGLLVGVLQHNMAFGHAAETYTLLTIGDG
LVAQIPALVISTASGVIVTRVSTDQDVGQQMVTQLFNNPRVMVLSASVLG
LLGMVPGMPNFVFLLFTAALLALAWRLRGKQTQQPVAVEAPVVQDQQQGA
EATWADVQLEDPLGMEVGYRLIPMVDFQQNGELLGRIRSIRKKFAQEMGY
LPPVVHIRDNLELPPANYRILMKGVEIGSGEAHPGRWLAINPGNAVGTLP
GEATHDPAFGLAAVWIESALREQAQIQGFTVVEASTVVATHLNHVLSQYA
NELFGRQETQQLLDRVTQEMPKLTEDFIPGVVTLTTLHKVLQNLLMERVS
IRDMRTIIETLAEHAPNQADPYELTATVRVALGRSIAQQWFPGNGEIQVI
GLDAALERLLLQALQGGSGLEPGLADRLLDQSKQALQRQEMLGAPPVLLV
NHALRALLARFLRRSLPQMVVLSNLEIGDNRQIRMTSTIGSA
>YP0428 flhB1, putative type III secretion system component
MMSTEKNEKPTPKRLKEAKEKGQVVKSVEITSGVQLVALVIYFLLTGYSL
VEQAKALIRSSIIQLQQPLTLALARIGAECMTVLMHIVVVLGGALIVVTI
IAGIAQVGPLLATKAVSFKGERINPIQNAKQLFSLRSVFELMKSLLKVGV
LTLIFGYLLMQYAPSFGYLTHCGSRCALPVFSTLMGWLLGSLIACYLVFS
LMDYAFQRYTIMKQLKMSHDEVKREYKDSNGDPHIKQKRRQLQHEVQSGS
FATNVRRSTAVVRNPTHFAVCLIYHPEETPLPIVIEKGHDEQAALIVSLA
EQSGIPVVENIALARALHRDVACGDTIPEQFFEPVAALLRMALELDYQPS
SDDPPR
>YP1602 flhB2, flagellar biosynthetic protein FlhB
MAEDSDQEKSEEPTASKLEKAREKGQIPRSRELTSMLMLGAGLTILWMSG
ESMARQLSAMVAQGLHFDHSMVSNDKQMLRQIGMLLRQTLLAMLPIFAGL
VIVALAVPMLLGGVLFSGESIKFDLKRMSPVAGLKRMFSSQALAELLKAI
LKATLVGWVTGLFLWHNWPDMMRLIAAPPVAALGDALHLIIFCGLVVVLG
LSPMVGFDVFYQITSHIKKLRMTKQDIRDEFKNQEGDPHVKGRIRQQQRA
MARRRMMVDVPKADVIVTNPTHYAVALQYNESKMSAPKVLAKGAGAVALR
IRELGAEHRIPLLEAPPLARALFRHSEVGQHIPATLYAAVAEVLAWVYQL
KRWKREGGLIPKKPEHLPVPEALDFATESETKSETD
>YP3018 flhB3, flagellar biosynthetic protein FlhB
MSNSSGEKSEKPTAGKLSKARKKGDIPRSKDVTMAAGLVTSFILLSLFLP
YYKALVSQSFVSVAQLASQLDDQGALEQFLLANLFIFAKFLATLIPIPLF
SMLATLIPGGWNFTPVKLIPDLKKLSPLAGIKRIFSASNGTEVLKMLAKC
SIVLYTLYLVVHSSLDDLLHLQTLPLEEAITQGFAQYHHILLYFIAIVVV
FAAIDIPLSHHLFTKKMKMTKQEVKQEHKNNDGNPEIKSRVRQLQRQYAI
GQINKTVPSADVIITNPTHFSVALKYAPEKASAPYIVAKGKDDIALYIRS
IAQKHKIEIVEFPPLARAIYHTTKVNQQIPAQLYRAIAQVLTYVMQIKSW
RSGQASKPVLNTHLGLPKEMQRFHDET
>YP1561 fliE1, flagellar hook-basal body complex protein FliE
MDKNRPDVCIARGVYNLRVNMSVQGIEGVLQQLQVTALQASGSAKTLPAE
AGFASELKAAIGKISENQQVARTSAQNFELGVPGVGLNDVMVNAQKSSVS
LQLGIQVRNKLVAAYQEVMNMGV
>YP3025 fliE2, flagellar hook-basal body complex protein FliE
MDNIDSINMPRSQSPVMLEMRQMAAMAGSGLEFGTIQPAATNSPFFPVEK
GANNLSFSQVLNGAIKSVDQLQHVASEKQTAMDMGISDDLTGTMLASQKA
SVAFSAMVQVRNKLTSALDDVMNTAL
>YP0417 fliF1, type III secretion system apparatus lipoprotein
MKSLRQMLAIVLMTLSLSGCDMELYSGLSEGEANQMLALLMLHQINAEKQ
IEKSGMVGLTVDKRQFINAVELLRQNGFPRQRFITVDELFPANQLVTSPT
QEQAKMVFLKEQQLENMLSHMDGVIHADVTVAMPMSVDGKNPLPHTASVF
IKYSPEVNLQSYQSQIKGLVRDAVPGIDYAKISVVMQPANYRFSASEAEQ
QQGPQTTVQWLLRHVGMVQNMVGVAFISLIVLMFVGWFYYRRR
>YP1562 fliF2, flagellar M-ring protein
MNASITGGENRENTFTMTLARLRANPKIPLLIAAAAAIAIIVALMLWAKS
PDYRVLYSNLSDRDGGDIVTQLTQLNIPYRFADNGGALLIPAEKVHETRL
RLAQQGLPKGGAVGFELLDQEKFGISQFSEQINYQRALEGELSRTIGTLG
PVLNVRVHLAMPKPSLFVREQKSPTASVTLALQPGRALDDGQINAIVYMV
SSSVAGLPPGNVTVVDQTGRLLTQSDSAGRDLNASQLKFTSEVENRYQRR
IENILAPMVGNGNVHAQVTAQVDFASREQTDEEYKPNQAANQGAVRSQQV
STSEQLGGTNVGGVPGALSNQPPVAPIAPIEIPQPAGAAANNAAPANTAA
TANANTTATAAKASSSNSRHDQTTNFEVDRTIRHTQQQAGMVQRLSVAVV
VNYTSDKAGKPIALSKDQLAQVESLTREAMGFSTVRGDTLNVVNTPFTAS
DDTRGSSLPFWQQQSFFDQLLNAGRYLLILLVAWILWRKLLRPMLAKKQV
ADKAAASVNNIVQTAQAAETVKQSKEELALRKKNQQRVSAEVQAQRIREL
ADKDPRVVALVIRQWMSNDQ
>YP3026 fliF3, putative flagellar M-ring protein
MLDKIKQKLSPGQLGENTKTILMSAVALLVTAAIIFSLWRSSQGYTALFG
SQENIPITQVVEVLEGEAIAYRINPDNGQVLVAENQLGKARILLAAKGIT
ATLPIGYELMDKESMLGSSQFIQNVRYKRSLEGELAQSMMALSAVEYARV
HLGMSEASSFAISNHADNSASVVLRLRYGQTLSTEQVGAIVQLVAGSIPG
MKPANVRVVDQHGELLSQAYQANSEGVPSVKSGTELAHYLQSTTEKNIAN
LLNSVIGANNYRISVSTQLDMSRIEETAEHYGPDPRINDENIQQENSNDD
MAMGIPGSLSNQPIPQSQAGQTPAAVSRSQAQRKYIYDRNIRHVRYPGYK
LEKMTVAVVLNKSLPVLEQWTPEQQEELKRLIEDAAGIDVKRGDSLTINM
MAFAVPTLIDEPVMPWWQEPSTFRWAELLGIGLLSLLVLWFGVRPLMKRY
SRKGSENLPLAISSASADEALDHVDTGVDGAESSPRTENAFSASSLWKSD
DLPEQGSGLETKIAHLQQLAQSETERTAEVIKQWINSNERIKSQPE
>YP1564 fliH1, flagellar assembly protein FliH
MAAARISMSDRINALPWQPWSLKDFASQSEAPLSESMPDISLLFPNEPME
ATAAVDEQQVLVNLQLEAEKQGRQQGFAKGLQEGLDKGYQTGLEEGHQQA
LADAQQQLAPMTAHWQVMVTDFQNTLDTLDSVIASRLVQIALAAAKQIIG
QPAICDGTALLAQIQQMIQQEPMFAGKTQLRVNPDDLAIVEQRLGSTLSL
HGWRLLGDSQIHAGGCKVSAEEGDLDASLATRWHELCRLAAPGEL
>YP3028 fliH2, flagellar assembly protein FliH
MPNRPWSKVMLIKNTPRAGAVKLRVHQFPPLRKVRQVAPSAADQTLDPAE
YQKQLMAGFQEGISQGFDKGLAEGKEEGYQEGVRLGHDDGLKKGRIEGRQ
SELASFNDVIKPFSGYITQLHTYLETYEQRRRDELLQLVEKVTRQVIRCE
LALQPAQLLTLVEEALAALPMVPQQLKVYLNPAEFGRINDVAPEKVQAWG
LAADPDMVGGECRIVTETTEIDVGCQHRLDQCIGALHSSFLTEPHHE
>YP0421 fliI1, putative type III secretion system ATP synthase
MMKLPDIARLTPRLQQQLTRPSAPPEGLRYRGPIVEIGPTLLRASLPNVA
QGELCRIEPQGMLAEVVSIEQEMALLSPFASSDGLRCGQWVTPLGHMHRV
QVGADLAGRILDGLGAPIDGGPPLTGQWRELDCPPPSPLTRQPVEQMLTT
GIRAIDGILSCGEGQRIGIFAAAGVGKSTLLSMLCADSAADVMVLALIGE
RGREVREFLEQVLTPEARARTVVVVATSDRPALERLKGLSTATTVAEYFR
ERGLKVLLLADSLTRYARAAREIGLAAGEPPAAGSFPPSVFANLPRLLER
TGNSDRGSITAFYTVLVEGDDMNEPVADEVRSLLDGHIVLSRRLAGAGHY
PAIDIAASVSRIMPQIVSAGQLAMAQKLRRMLACYQEIELLVQIGEYQAG
EDLQADEALQRYPAICAFLQQDHSLTRDPDTAHLDTTLEHLAQVVG
>YP1565 fliI2, flagellum-specific ATP synthase
MPVWRPVGMNCAVWPRRGNCDAPRLSRWLTSLDKFEERISQTTTIRRYGR
LTRATGLVLEATGLQLPLGATCLIERHNGGEVQEVESEVVGFNGQHLFLM
PLEDVEGIVPGARVYARVTTSGTSASKQSISSKQSIPSKQSFASKQLPLG
PELLGRVLDGSAKPLDGLPAPETGYRAPLITPPINPLQRTAIVQVLDVGV
RTINALLTVGRGQRMGLFAGSGVGKSVLLGMMARYTQADVIVVGLIGERG
REVKDFIENILGAEGRARSVVIAAPADVSPLLRMQGAAYATRIAEDFRDR
GQHVLLIMDSLTRYAMAQREIALAIGEPPATKGYPPSVFAKLPALVERAG
NGVSGGGSITAFYTVLTEGDDQQDPIADSARAILDGHVVLSRRLAESGHY
PAIDIEASISRAMTSLIDDDHYSRVRQFKQLLASYQRNRDLISVGAYAAG
SDPLLDKAIALYPQMEAFLQQGMFERSSFDDACQHLKVLFPG
>YP3029 fliI3, putative flagellum-specific ATP synthase
MSESPALDHALKSIENIHLARVAGRLVRVTGLLLESVGCRLAIGQRCRIE
SVDETFIEAQVVGFDRDITYLMPFKHPGGVLGGARVFPSEQDGELLIGDS
WLGRVINGLGEPLDGKGQLGGSTPLQQQLPQIHPLQRRAVDTPLDVGVNA
INGLLTIGKGQRVGLMAGSGVGKSVLLGMITRYTQADVVVVGLIGERGRE
VKEFIEHSLQAAGMAKSVVVAAPADESPLMRIKATELCHAIATYYRDKGH
DVLLLVDSLTRYAMAQREIALSLGEPPATKGYPPSAFSIIPRLAESAGNS
SGNGTMTAIYTVLAEGDDQQDPIVDCARAVLDGHIVLSRKLAEAGHYPAI
DISQSISRCMSQVIGSQQAKAASLLKQCYADYMAIKPLIPLGGYVAGADP
MADQAVHYYPAITQFLRQEVGHPALFSASVEQLTGMFPSFAPTDEA
>YP1566 fliJ, flagellar protein FliJ
MKSQSPLVTLCDLAQKAVEQASTQLGHVRQSYQNAEQQLTMLLTYQDEYR
ERLNDTLCNGMASSSWQNYQQFIQTLEQAIDQHRKQLAQWSIKVEQAVKY
WQEKQQRLNAFETLQERAETTQRQQENRLDQKLMDEFAQRASQRSLNL
>YP1570 fliN, flagellar motor switch protein FliN
MSDPKFPSADGKESVDDLWAYAFNEQQATEKPTATTEGVFKSLEAPEGLG
NLQDIDLILDIPVKLSVELGRTKMTIKELLRLSQGSVVSLDGLAGEPLDI
LINGYLIAQGEVVVVADKYGVRITDIITSSERMRRLSR
>YP0424 fliN1, type III secretion system apparatus protein
MLTNLTPELRALSTLIGSGRQTAGVSVALTEIDGEGVYLPLHYGGQECGL
WLSQSCWQHWLNTTLATDNPQLLAAELVIAMANWAVTPLLALFTDLVVLA
ESPQKRSLPKQWAVTVAFELEGQPIIGVLQDWPQAALADTLSHWPCEAVT
APDLLWQSGLVAGWCHLSLRQLQQLRPGEGLRLSMAAELDKEACWLWHHA
SPQIYIKLEGGNRMTIQQINEASDPLACGSRAESPPLAAVQLEDLPQTLV
MEIGRLTLPLGEIKQLAVGQTLACQTHCYGEVNICLNGQSVGRGSLLRCD
EKLVVRIAQWGLQNGENIME
>YP3022 fliN2, flagellar switch protein
MTDQQIELNNDLDFTLALDESAISPTEHFDSVINSPEIINTPEKTATKTD
EQKRKMSLFSRIPVTLTLEVASVEIPLSELLTVNNDSVIELDKLAGEPLD
IRVNGIMFGQAEVVVINEKYGLRIININSQNLGELAL
>YP0425 fliP1, putative type III secretion apparatus protein
MLSVLPLLVVMGTAFLKLSVVFSLLRNALGVQQVPPNIAIYGLALVLTIF
IMAPVGLDVQARLQNEELSNDIGALAHQIDQNALVPYRDFLQRNTDIEQV
TFFNDIVQNKWPERYRDSVKPDSLLILMPAFTLSQLNEAFKIGLLLFLPF
VAIDLIVSNILLAMGMMMVSPMTLSLPFKLLVFVLVDGWSLVLGQLVGSY
L
>YP1572 fliP2, flagellar biosynthesis protein
MTSHRPVFISKRSLITGALFCRMWRTIIMSVINKTTLGLLTLFCSPSVLA
QLPGIISQPLANGGQSWSLPVQTLVFITTLSFLPAALLMMTSFTRIIIVL
GLLRNAMGTPSAPPNQVMLGLALFLTFFIMSPVFDKVYQEAYLPFSQDKI
SMDVALDKGSQPLREFMLRQTRESDLALYARLANLPPLEGPEMVPMRILL
PAYVTSELKTAFQIGFTVFIPFLIIDLVVASVLMALGMMMVPPASISLPF
KLMLFVLVDGWQLLLGSLAQSFYS
>YP3021 fliP3, flagellar biosynthetic protein FliP
MSRSLRAITPVTIISRGLLVGGLLYSPLLLAQEGGITLFNTVQTATGQDY
NVKIEILILMTLLGLLPIMMLMMTCFTRFIIVLAILRQALGLQQSPPNKV
LTGIALALTLLVMRPVWTKIHQDAVIPFQQDEITLSQALGRAEAPLKNYM
LAQTSTKSLDQMMAIAQVSGEPQQQDLSVVTPAYVLSELKTAFQMGFMIY
IPFLVIDLIVASILMAMGMMMLSPLIVSLPFKLMLFVLCDGWTLMVGTLT
ASVQGL
>YP0426 fliQ1, putative type III secretion apparatus protein
MNNHMSSYHENAIIVHLATELLWLVLLLSLPVVVVASTVGLVISLVQALT
QIQDQTLQFLIKLLAVSATLLMTYHWMGATLLNYTQQSFLQITSMRP
>YP1573 fliQ2, flagellar biosynthetic protein FliQ
MTPESVMALGTEAMKIALALAAPLLLAALISGLIVSLLQAATQINEMTLS
FIPKILAVFTTMVIAGPWMLNLILDYMRNLFTSLPTLIG
>YP3020 fliQ3, Flagellar biosynthesis/type III secretory pathway protein
MMTTDIAGDIIAMGLHLVLMISIVAIVPSLLIGLLVSIFQATTQINEQTL
SFLPRLVMTMLVLIFAGKWMMIKLSDFTVSIFQQAAQLVG
>YP0427 fliR1, putative type III secretion apparatus protein
MTDVLPGLTALALAMMRPYGILLILPLFTARSLGSSLLRNGLIVAIALPV
TPLFLSAPIITNSSPVTWIGVLCTELLIGVVMGFVAALPFWAMNMAGFLI
DTLRGATMSTLFNPGMGVESSLFGVLFTQILTVLFLISGGFNQVLAALYG
SYDSLPIGQGIQPAADLLLFLQTEWQMMFELCLCFALPALLVMVLADLSL
GLINRSARQLNVFFLAMPIKSALALFLLLISLPYGLHHYLSRMSDTEQKI
GTLIPLIKGGNDVH
>YP1574 fliR2, flagellar biosynthetic protein FliR
MLSFDTHQLSVWVSQYFWPLVRVLALIGTAPLLSEKQINKKVKIGLGVLI
TFLIAPSLPPVNIPLFSSAALWVAIQQILIGVALGVTMQFAFAAVRLSGE
VIGLQMGLSFATFFDPSGGPNMPVLSRLLNILVTLLFLSFDGHLWLISLL
ADSFHTLPIQFAPLNGNGFLTLAQSGSMIFMNGLMLALPLITLLLTLNMA
LGMLNRMTPQLSVFVIGFPLTLTVGIISLGLIMPLLAPFTEHLFSEFFDR
LAEVLSGMAN
>YP3019 fliR3, flagellar biosynthetic protein FliR
MGIDIHAMTAPLFALWLPFVRILSFLHFCPVIRHKAFTRKAKIGTALLLA
ILITPMISQPVVSGELLSIENLLLAGEQILWGWLFGSMLHLVLAALEAAG
QILSMNMGLGMAMMNDPTSGASTAVISQIIFTFSVLIFFTLNGHLLFVTI
LLKSFSSWPIGEAINDFSLRSLALSLGWILSSATLLALPTTFIMLIVQGS
FGLLNRISPTLNLFSLGFPIGMLFGLLCLLLLAINIPDHYLHLTNEILTQ
FERMKVH
>YP1553 fliS1, flagellar protein FliS
MYKRSGSQAYAQVGLESGVMSASPHQLIVMLFDGAQSALIRARILMSQGN
IPAKGAAISKAIDIINNGLSAGLNLDKGGEMAENLSALYDYMSRRLLYAN
LHNDEQAINEVSALLENIADAWRQIGPNYQPN
>YP3050 fliS2, flagellar protein FliS
MMYDEPMAGLYQQTDIAIQAAATPHQLVMMLFDGLRDELICAKGHIEAGR
YEHKVKSINKCINILNGLTSVLNYEDGGDLSVTISKLYDYCVYRLYEASN
LLSIEIIAEVEGILAALYQGWEGMKH
>YP0147 ftsA1, Predicted ATPases of the HSP70 class involved in cell division
MDTFFYSVSTWRSIKMYSQYWQVGLDIQMEAIRALAVIRRRNGWQLRYWW
HKILPSGVLREGILHQPDILSEQLKLLRKQLPRHISLRIALPAQRILQHT
IHVPDRRLREPERDGFIKASASRLFPVNSQALALDYCRETVASSELLITA
ARQSEVQQWQACLEQAGLSSQVIDIAPCALRYMATATGLSGPYWLVHRLA
NEWLWVSSSDMPFHSGVVAIETECRTQENDIRLLSALLAQLNMRGAGEDG
APLPVYYSSVVKESLPENTRSWSPLTAFAHYQPPLPALPAAFTLAGGLAV
RAADSLSAAGAGY
>YP3235 ftsY, cell division protein
MAKEKKRGFFSWLGLGRQSEEPAAEPLATEKEGVTEQEDVIEQTGVIEPT
DVIEQTVEHVISEKTTEAPAENAFIEVELREQVAAVIPTEPNNAIMSEGV
PDTLPERAVAESVVAELVETGDNAAIVHDEIIEPITQVTEAGGELSLVKP
GIEGDTTEQGGPTDNLPKRSLTEDNLIIDVPTPQAVVEESRVDAVEQPTE
TSEVEEVEEVEEVEEVEEVEEVEEVEEKIIPVAAQEQERPTKEGFFARLK
RSLIKTKQNLGSGFMGLFSGKKIDDDLFEELEEQLLIADVGVETTRKIIT
SLTEHTSRKQLKDADALYGKLKEEMSEILSKVDKPLDVSGKSPYVILMVG
VNGVGKTTTIGKLARQFQAEGKSVMLAAGDTFRAAAVEQLQVWGERNKIA
VVAQHTGADSASVIFDAIQAAKARGIDVLLADTAGRLQNKAHLMEELKKI
VRVMKKLDGDAPHEVMLTLDASTGQNAVSQAKLFNEAVGLTGITLTKLDG
TAKGGVIFAIADQFEIPIRYIGVGEGIEDLRPFKADEFIEALFARED
>YP0152 gspD1, putative membrane transport protein
MQALADYRQLNLITTTGVGGNLSLRLIEVPWEQALAIILRMGRLKAEREG
TVMMVFTEQEIQERQQRTKQQAAPEALANLTLALQYANAEQVADSLDPLQ
GGLLSPLGSVVADKRTNTLLIRDTPASLALLKNWLIEMDLPLQQVQLSAH
IVTISSEDLQELGVRWGMGEGKGNTALRINDFNVNLPLPNSAASVGFHVA
RIGGRLLELELSALEQENQVDIIASPRLITSHQQTASIKQGSDIPYTVSR
GKKEAAAIEFKEAVLGMEVTPKILRNGKIILDLKISQNMPGITIKRGESE
MLLIDKQEIKTQVTVNDGETIVLGGIFQQKKRQSVNKVPLLADIPLLGAM
FRQDTQQQSRRELVIFITPKLISA
>YP0410 gspD2, possible type III secretion protein
MIVGLRQKPYLNLRNYKWMSLIYIMRKITGLILLFFATLLPYGKFSYVKA
IPWQGEPFFIYSRGMTVSELLKDLGMNYGIPVVISSEINEHFTGKIRDKT
PEKILSELAGRYNITWYYDGETLYFYPVQSIKREFISPDGLAANTLVKYL
QRGDVLAGKNCAIKAIPHLDTLEVKGVPICIERVKSVSKMLSEQVRHQNQ
NKETVKVFPLKYASAADSDYQYRDQNVRLPGLVSVLRELNQGNNLPLAGG
NQPDGNQASSPVFSADPRQNAVIIRDRQANMPIYRSLITQLDQRPIQIEI
SVTIIDVDAGDISQLGVDWSASASIGGTGVSFNSTFAKNNAEGFSTVIGD
TGNFMVRLNALQKNSRARILSQPSVVTLNNIQAVLDKNVTFYTKLQGEKV
AKLESVTSGSLLRVTPRMIETEGVQEVLLNLNIQDGQQQASTNSNEPLPE
IRNSDISTQATLQVGQSLLLGGFIQDTQIESQNKIPLLGDIPLLGGLFRS
TDKQSHSVVRLFLIKAVPVNAGE
>YP2840 gspD3, putative general secretion protein
MYISGKGIKSIHGMIFLFTLIMPLDIISANFSVSFKDVDIKEFINSVSKN
INKTIIIDPTVQGLISIRSYENLDKDTYYQLFLNVLDVYGYAAIEMPHNV
LKVISSKRAKGVVAPLPKEGVTFDGDELINRVIPLRYISAKKITPLLRQL
NDNTESGSIINYDPSNILLITGRAAVVNRLHSIVTDLDQAGDNEIELYKL
NYAIAADVVKIVNEAINPINNLKQEVSIVGKVIADERTNSILISGDTYIR
KKSILMIKKLDKRQSSDGNTKVVYMKYAQASKLLDVLNGISEGFHNEKKT
KQSNQWNQRPVAIKAYDQTNALVITADPDMMLALGEVIEKLDIRRAQVLV
EAIIVETQNGEGINLGVKWENKRSDDINFIKNSDGLLNNNGWGIATTITG
LTAGFYKGNWDVLLSALSTNTNNNILATPSIVTLDNMEAEFNVGQEVPVL
ISTQTTTTDKVYNSISRQSIGVMLKVKPQINKGDSVLLEIRQEVSSIADS
STVNTHNLGSVFNKRVVNNAVLVKSGETVVVGGLLDKKSSTIVNKVPFLG
DLPLIGWLFRQTKEKVEKSNLILFIKPTILRESDDYSVVTSKEYNKYKKD
NMNGYTLADDIVLSDKKYLSVIPSIRKDINNFYTLLDSEL
>YP2841 gspE, general secretion pathway protein E
MTDIESEFHTLPLTFSWSKSHGVLILPMAQGSQLICRKSATLEAILEGNR
VAHSPILFNLVTDEEFENNLTERYQNNSADPYQTMSVISNEIDIYSFANE
LSDDDDLLDINDEAPVIKLINSILVEAIKELASDIHIESFDKKLTVRFRI
DGVLRKILELQRHVALLLVSRIKVMAKLDIAEKRIPQDGRIALNLAGRAL
DVRVSVLPSSHGERVVMRLLDKNSIKLDLPSLGMSKDNCISMNTQVHKPH
GIILVVGPTGSGKSTTLYAALMGIDANEKNIMTVEDPIEFDIPGISQTQV
NPKIEMTFARSLRAILRQDPDVILIGEIRDIETAQIAVQASLTGHLVLST
LHANSAIGAVTRLKDMNVEAFMLSSSLLAIISQRLVRRLCIACRQESSVT
EKVLQRLNIDDKCSLVGSVYRAKGCNKCNLTGYRGRIALHEFLVVDNLLR
GAIYKGLGEFELAKLASGAINSLLSDGISKVIAGLTTIEELVRICQEDDN
GCI
>YP2847 gspK, general secretion pathway protein K
MNQNGIALLMVLCALFLMSTMVMASYNYWFDIYYLAKNSQQRQKEKWILL
GAEEKFVSKLIKNTSEDRFNDNEFRRLLSGGRVTVGTWNVNFKSIDNTNC
FNINALKTKISNPEEIIETYSWQVFKYLLLISGVGVKETQDTLERVVELY
RSNLVIEQSINGLSTLKEIPYEADEINISSKMNRADFLKIAPVLCIRGDR
KLLVNINMLDAGNSQYLQAALLNKVSARDIYDVISAKPNNGWDNIFIFYD
LLSSHSPMSARNVNKNILDKLTVDEYFINYIFRIDHEDSYYQLITFIHAV
GKSIAILNRRYSFSEQHH
>YP2848 gspL, general secretion pathway protein L
MSNIIDDVKLTFTLLIRLGETEFEPIYWYVESQGKKLVRHGKINGVAELK
NITLYANNVVKILVPANKIIFRSLSIKKNEVMNNIKSIAFSIEQSISSDI
DNFHIVILDQDKDFCHVAAIEHELMNRWLFWLNINGISACCIMPDAFALP
FFNSEWSVIKIESNWLVRNNEMSGFLVNSSVLENILMLAEPTIKVNTFSP
TDIKWGNWQSLDYSDPVLIMAKTVSGNHVNLLSGKYKYAERIIVNNSVFL
RVASWFFLLFLVMSLNGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGG
DVNTSFNKYISDLDLKKNNVSFIKLLNAVSYYTADENVDVRSFNFNYSDG
EISFDIEGDDDLINEMLNDKTNLFNARVEVIRSGEDKYNIKLSSQP
>YP2978 hasF, ABC-transporter outer membrane component
MQMKKLLPLLIGLSLAGFSTMSQAENLLQVYKQARDSNPDLRKAAADRDA
AYEKINEVRSPLLPQLGLSAGYTHANGFRDASNSPDSNATSGSLKLTQTI
FDMSKWRALTLQEKAAGIQDVTFQTSEQQLILNTATAYFNVLRAIDSLSY
TEAQKQSVYRQLDQTTQRFNVGLVAITDVQNARASYDTVLAAEVAARNNL
DNALESLRQITGVYYPELASLNVERLKTQRPDAVNNLLKEAEKRNLSLLS
ARLSQDLAREQIKSAETGYMPTVDLTASSSITNTRYSGGTPSSQQVNNDS
GQNQIGVQFSLPLYSGGATNSAVKQAQYNFVGASELLESAHRNMVQTLRS
SFNNISASISSINAYQQVVISNQSSLDAMEAGYQVGTRTILDVLTATTNL
YQSKQQLADARYNYLINQLNIKSALGTLNMNDLMALNAVLDKPVPTSAAA
LAPENTTRQTVTTPRAQ
>YP0685 hmwA, putative adhesin
MNSKLYKLIFCRRLGCLIAVGEFTRSYGRAFSSKGGQAGNNQRRAVGILS
RLAMMTGLALGIFPLLVLAHPVLPVNGHVVIGQGMLDQQSSTLTVTQQTD
KLAINWDSFDIAHGHSVIYAQPGSQSIALNQVQGQSASQIYGRLQANGQV
FLLNPRGILFGKEAQVNVGGLVASTKYMSNPEFLSGDYRLIGGESEGNII
NQANLRSAPGGYIALVGNRIDNQRSGSITTPQGNTVLAVGHSVTLNLDHG
NLLGVQIQGETVAALIQNGGLIQADGGVIQLTAKGKDMLMDTVIDNTGIL
QAKGLSAKNGAIYLDGGGEGVVSQMGTIDVNNQQGRGGRAVVEGKRIYLN
KNSNIKAKGTAGGGTVLVGGGWQGKDNQIRNATAVVMDKGSDIDVSASRN
GPGGSAVLWSEDYTGFHGNIRARGGPQSGDGGQVETSSQRNLQAFGQVDA
SAVRGSAGYWLLDPAEVTIVSSGAESGVMTKVGNIPAEFFSSAHIFIPTA
NITQILNSSINTQLNSGTNVTITTSNSSLTGCQWCNITVQADITKTAGAD
ATLTLQADGNIVVNNNITADAGKLNLNLLAGNTTADSAITLNNSKVLLNG
GDFLAKHANDNNTARIGLLGGRYDVGNFTLDGNTALASQVGVNISNAANI
SVAGETVISGVSSNSRGQGWRGIDISNNSILTGVGNMTFSIGSNSNVSWM
GAFTNATITSDKNIIFQGTGSSSGGVDFVNSRILSKSGRVLFDINGNIVV
KNVYGLRVNNSQLSAKDVKFAVNVTGVDGFLLRDSHVTATSGDINANANT
INKGIWISGKTNLNASGNVNLHGVTTNSAYAGADAIKISGNSSSNNVNIT
AGGHISLIAVNGGKEIGSTVSVDYANIIAKNGDFNLNITGMKGSPFNNAT
ITANNISMNGNITANDAVLMTNTFLTAKGDIKTDLTSPTKGLWFRGNGGM
TAANNILLVANSTSSGETVKINASSSNKMNITAGKDISIIAGNSKTATGP
NINIENVNIETNNGNFTTNGITSTWLSGVNVSANGVDITSNSTGTGGIVL
DNTNILTTVGDINTIVTNSSGKGIWIKSNSTLNSNKDITLVGVSAGQNEG
VIIQGSSDASRNNISAQGNITLIGKMGNGSGQHSLINLGNVSLTSSGRNI
DINGSSAGTGDVYFTNVELNATAGNVSIYAETKTALSTSLNAVLSLGGNN
SIKAQNGWLIGKAFNTTQGAGIGFRANSSLSVDGNIILKGETEGVGATRK
GIDFYGANTLNIIKGSQLSLLGENKGAQDTAGGNGISYTSPAKLTVNNNG
SLKMEGRSTSGTGINFPSSNNTLVFNGDGDTLIKGSSVAGTGAAISGVVN
NSTGPMTIEGISTDGAGVHLFSAEHRIDRINVTGSSTHAEGLRISGNAAI
VDTTLTGKSINGSGVKIDSLPGSSVVTRSVLDNATLNGSSSSGKGVEITS
DINGIHHSSINGTTTGTGYGIDIGENSNVTGTSEADLLILQGVATTGTGT
GIKLNGNNDLSNTSLNSSAVDGIALDITGPLANQGNVILNGTASGSGIGA
QVNGSLSDSVVNGTSTNGIGVQINGSLKNSRINGISANGSGVKIDGESTL
DNATLNGNSTEGKGVDLAANLSGNHGSVVHGDTVHGTGIDVGKDVTLSGG
GTDEPLTVSGNASGEKGTGVQLGGNNTLDNTTLSGNATDGHGVEINSRLI
NNGNTTINGKTSDDGHGVHINGAISGGEINGHSDNSHGVFLDESALLNDI
VIGGGTGSYKLPVFIALPETIGERVTLNGKPIDKTQPEGSKAREGDNLTR
GKYTPLPPATDPELPPASTDEEKNTKQTSTLTPSQKREDPDMLIMARNHI
LSTLEGRDLSSSVVTESEQSAAGVTGIMVCLPLSETSEHEPCDTYILDKG
QPHLPMMVKK
>YP0258 hofB, putative integral membrane protein
MIRPHQMAEFIVSSFETISDELHLLCRRYRAVALTLDGKSLSIASAQTVD
EALLTALRFTCGRQVRVEYWPEAKIEQSLYLGSPTKNNLNSSINNGLNSA
LLSQKGGDPSRVKPHNQQQQTIDDTVFDNESDTPVIQFITQTLSLAIQKR
ASDIHFEPYQHHYRVRLRIDGVLHEFTPPEAEWAARISSCLKVMAKLNIA
ERRLPQDGQLTLPFGDSHYSMRIATLPTQYGEKVVLRILQIQQQTTLEKL
GMTDAALKQLTQALSAPQGLILVTGPTGSGKTITLYCSLARLNQTQRNIC
SVEDPIEIPVNGINQTQVNSKIGLDFSRILRAILRQDPDVIMVGEIRDNE
TASIAVNAAQTGHLVLSTLHTNSTAETLIRMAQMGIERHLIASSLKLVIA
QRLVRRLCLHCRQAASHPFIPPAHIRSGPIQHYLAVGCEHCCTGYYGRTG
IYEMLSVTPQIQQAILNNASPVKLVQIAQKQEQTALLCSGLALIEKGITT
LSEINRVVGFVAETEVTS
>YP0257 hofC, putative type II secretion system protein
MSRHRLFNWTALNKTGELQTGMLLATERNSVYEHIIQHGLQPLGVKGGRR
LSARYWQGERLVAMTRQLATLLQAGLPLVNSLQLLAKEADDSAWRCLLDE
ISQQVAQGQSLSEVMEQYPHVFPRLYPPVVAVGELTGNLEQCCTQLVHHQ
ERQQNLHKKVIKALKYPVVVCIVALVVSVIMLVMVLPEFAQIYQSFDTPL
PGLTASLLWLSTFLTFYGPYLALIIAIVCIGYFYTLRKKSRWQQWEQTIL
LSIPLVSTLIRGSCLSQIFQTLAITQQAGLPLSAGLDAAARSIHNYNYQQ
ALRCIQKQISQGIPLYTTLNQHPLFPAICQQLIRVGEESGSQDVLLEKLA
CWHQQQTQNLADNVTQMLEPLLMLIIGSIVGVLVIAMYLPIFQLGDVIG
>YP2842 hofF, putative general protein secretion protein
MIMAVFKYVAISRSGTKITGDIDAENIRIARYLLYKKNMHVLSIKKRILL
FNKYVVKKNSNKTDLVLITRQIATLVNASMPLDEVLDIVGKQNSKSKMIE
IIQRIRVNIQEGHSFADALSPFPAVFSPLYKTMVTAGEVSGHLGLVLVRL
ADHIEQTQKIQRKIIQALIYPCVLVLISLSVIIILLTAVVPNIVEQFSFS
ETALPLSTKVLMILSYSIKENVIFIMAIGVSAVIFLNRLLKINKINVFFH
RHYLSLPMLGNMFVRINTSRYLRTLTTLHSNGVTIVQAMSISNAVLTNVY
IKNKLNISVKLVSEGCSLSSSLVDSGVFPPIILHMIISGERSGKLDHMLE
TVAGVQEEELMNQISIVMSLLEPTIIIVMAAFISFVILSILQPILEINSL
VM
>YP2843 hofG1, general secretion pathway protein G
MANKKTKGFTLLEIMVVIVILGLLASLTIPSLMSNKNRADQQKAVSDISA
LENALDMYRLDNGDYPTEQQGIAALVTKPNVPPLPQRYPSDGYIRRLPTD
PWGNSYQMNNPGKHGQIDIFSIGPDRLPETEDDIGNWITLSISET
>YP2844 hofG2, General secretory pathway proteins G and H and related periplasmic/secreted proteins
MILVIGLLYLSVRHRSMFHSQRAFTLLELLLAMIIISGLYYSVLITLPKG
SGVVKSEAENLVQGLRYINQKIRHEGGVFGLKLSETHWRFYKFCCDDCHG
IKDNFKINTKINCIWQDSGNDKILSREYPDKLTSKLNVYGEDSIIDNVIG
DNIKPQLVFSPEEEYSDFSLVLRNEENSECVEIKNNITGVSLFIHK
>YP2845 hofG3, general secretion pathway protein I
MLEVIIALTIFCIAGLSIMKIISERLRWINILEQRMISSWVAENVLTEIK
ILKIEQTNEWLMGQESMAGQLWYWQSRSIKLQDDRMEIIAVEVRNNKESE
HPDFSLEGYKTTND
>YP2846 hofG4, general secretion pathway protein J
MKAIKQPMIKRPDCGFTLLEMLLAVVIFSMISFIIYSSLRVTIKSNNIMG
NKVQELIRLHRVISLLERDISHSVMYIGSQNDYFSNEGRIIGIGVLDSDS
FGIYMLRNNKINTEIFIHYQHERLGYRLKKNCLERLSYLILKNTNKIETK
FSCLIEGINDFRVRIFHQGKWLNEWSRIDLSPQGIEIILDVKGVGVIRRF
ILLLH
>YP2877 hofG5, putative prepilin peptidase dependent protein
MKIYSIKTGKLLPKAPLLRKQKVFIKQRSLIKQRGISLIELLVVITLVSV
MTLWGGQSWHHYRQRAKLADSARQLLAFLTHLQAEANRNNRTAILWAQPD
GQGCLGSGHKPTPPCTGLAGSLFIPPYRDIAITLPLQKEMGFYGVRNTAQ
AGNIILSSPAGRIRLVISSRGRIRLCSEQQSMAGIHLCL
>YP2878 hofG6, putative prepilin peptidase dependent protein
MPLVVNVLSTPLNAQPTRTAGFTLPEMMLALSFGSLIALSTAQVLPKLSQ
QISVLQQHYRLELVMNQAMGAMEKDLRRAGFCHGKCQGEAITIEHYLGET
AHSCLIVAYDLNCNGRWEGAKHQESEYFGYRLRNKALESQRGELNCHGRG
WEKLFDPRDVTVTHFSVTPLSGQLFKLRLVGHKTGNPAIHHQVTYLIRGN
NV
>YP0684 hxuB, putative surface-exposed protein
MRDCYCHGMLWFPLKFSLLALFSLSCSPLIATPQVLNVPNAGAISNEIRQ
TTIEPLNAPEETDIKLPQLNKPTPPEGGLATERITLHRVRFEGDVSLFQP
GITADNKDLQALITPWLNRSLTFNDLQAMTFAVTRFYRKKGWVAAQAILP
PQTIRDGIIVVRVIAGRLDKPQINNQSSLNSHFITTVIESNSCSKKNGIF
GDKDCAASPVELSRLERTALILNEIPGVEASLALKPGTQSGMTRIYADVT
PGKKMMAYLAADNQGNDYSGHNRLLTGGVLNNLTGWGDQLRADLILSSSA
DVFNGLLDYNFPINSYGTRAALNYSYLDYTLTGPFSVLDARGHSTTWGIN
LRHPWIRTSAARIDVNAGYYQARMRDALILLPEQKRNLNAGEFGISGTFT
ALPRGLSNFNLLGTAGDLALDDEYSQSINTLTHVSGNFSRFNYRVGHDQG
IGSHVSFFNQFTGQMASKNLDSSQKLLLGGPLAVRAYGIGDGSVDKGTIF
TTELRTRWQPDFPDWAGYGHQITVAAFFDQGWGAYYRQPIVGLSENNINI
SGFGSYITFARPADYFLNLTWAHRTGQAVTRHQDNDQLWLSAYKMF
>YP3083 hylA, hemolysin
MRTPCYSYQEISPQNGDVKMKKHTFKLSPAGKLAAAVTIISVSVATCYAA
GIVGAGDSAHKPDVSSVNGTSVINIVQPSASGLSHNQFQDFNVGEKGAVL
NNATSAGNSILAGQLAANQNLNGQAASIILNEVISRNPSLLLGQQEIFGM
TADYILANPNGITCNGCGFMNTNRESLVVGNPLIEQGSLKGFETFNNNNW
LIIQDKGLTANKILDLIAPRIEVTGMVTSTEAINALSGNNQISTDGQILE
SRQEDHPNRPTSLGGWFSSLFSSESEESIDGKYLGSMQSGRINLVSTREG
SGVKIAGSLNGSEEINATIKGKLQLEAAKLGGNDININANSIQAFGNLHK
NEDNGGVTQSLERTQLKGKNIAIVANKKNQLSAVKIDADNVTLRGGELVL
DERILTKTEQESSSDGGNGVLGLGKWNWSENKEEKQQTSIGTTITAKNNA
SLESTQDDIKLSAATITAGKNLAIKAKKDLHIDGAIEENSIHDYGHNYKH
MVKDESWNNKTTKQTLNKTTLEAGKNLGLTAENKITTQGIKASAGGDVVI
DANDVKIGVQKTSNQETTDGKHERNLGLGGVDHNNNDKYAETSHSSEITA
DGNILISVKDDVAITGSKVKATKDGFVQAKEGGIKIDNAISTTTNKVDER
TGVAFDITGSSKKANNSEEKSTGSEVVSEANLKIISKKDVDVIGSLVKSA
GELGIETLGDINVAAAQEKQKIDEQKTLLTIDGFTSDDGKNQYQAGLKVE
HTSESEKTEKVINHGSTLEGGTVKLEADKDVTFTGSQLNTTKGDADITAE
NVSFVAAQDTTTSNKEKETVGVNAHYTGGMDKAGSGAGVSYEETKTDSEK
STAVVSHTDVKGDLNLNAKQEITNQGTDHNVEGSYAANATNVNNLAAENS
ETTTTTTNTVDVKYGGNIAYDGVTRPVEKTIESGKKLDVGGVIENVGNVA
PDSVNAGVDLSVNVGEKENKSSNSQAVVTSIKSGDISITAKEDVKDQGTH
YQADKGGIKIDAANHTFESAVNRAEESEKVVSGGVDMRIYTTTGEDINVD
AKGKGENKQQEVKAEQAQTGSMKAVGDIIINVQENARYQGTDLDSGDGKI
AITAGEEIKFEQATSHLSENHNKIDANAKANFGTKPNSKDFGGGLGGGHS
QGSTSADIAQVSHLHGKQGIELNAGKDLTLQGTEFGSKNAATGDVQLTAG
GKVDFQAAQSQSSKQDMTWSASVKAGKSKSNSTSENDDGTKTHTNNKGFS
AGAEANVKNTDETSLTHQGGIINSNGAVTIKADGKDQQAIHLQNTNIISQ
ETILNADNGGIVMESAQDKEHKNNWNVNTNLNGSQKNTIKSDDQGVVDKD
SAKKIHNAAIKLDGGVDKLDSVTQQNTHINSDKVTLNSAKNTELAGAVLQ
ANQISGQIGGDLNVISRENRLNKVNVSAALGGSHSNAKQDSLISQVANAS
PIMSDKIKNKLEEKSTKIFDKVENKFNTLGKEKDDSVQTISYTKDGQTVK
ISEADEKKETKDKWWQKGAKSVGKKIKSAVQDEQVVGGNGSVKANVEVVE
SQGVEEQSAIRGTQNVDLTVKGKTDLVGGKISSKNSDVKLKTNGLETQDI
NGKYTEGGARLNASSSVMDMISDGAKDVMDGKAPLVSGHGKSEQKNATGG
ITRE
>YP0602 ibeB, probable outer membrane efflux lipoprotein
MFSRILILSLPALLAGCISLDPDYQRPVAPVPATLPYSTASSSKAADIPW
QETIIDPKLRQVIALALESNRDLRQAIADIEAARAQYGVQRAAQIPTVNA
GVNGSRGRGLSDTSDGNNNTAISQSYGAQASVSAFELDLFGKKSSLSHAE
FETYLATEEAAKTTRITLIADTATAWVTLAADQNQLLLAEETLKSAEQSL
KLAQLRQKNGIASRIDVAAMETLYQSARADVAQYKTTVAQDKNALDLLVG
QPVAAHLLPVTASTLPEVIKAVPVGLSSDVLLNRPDVLEAEHKLKSANAN
IGAARAAFFPSVTLTASGGVSSSALSTLLSEGAGIWSLAPAITLPIFDGG
ANRAALEYSQAQKTGYIAAYEKAIQTAFKEVADALARKATIQEQRAAQQA
YVAAAQESVELAQKRYKQGIDTYLNMLDAQRTLYAAQTRLIAVQQIQTNN
LITLYKVLGGGVSDVAKE
>YP2521 lepB, signal peptidase I
MANMFALILAIATLLTGIIWCFERFKWGPARQAKIAAVNAQTAEIKAQTG
CAVDNKTLAQAAKQPGWIETCASIFPVLALVFIVRSFIYEPFQIPSGSMM
PTLLIGDFILVEKFAYGIKDPITQTTLIPTGKPNRGDIAVFKYPLDPRLD
YIKRVVGLPGDRVIYNPISKEVTVQPSCNTGTSCDSALAITYSTSEPSEF
VQTFRYSGNGESSAGFFPIPLNQAVPDGGVRLRERTESLGPVAHHILTVP
GRQDPLGSYYQQPDQPLGVWVVPEGHYFMMGDNRDNSADSRFWGFVPERN
LVGKATAIWMSFEKQEGEWPTGVRLSRIGGIH
>YP1978 marC1, putative membrane protein
MSQSLLDLSGYIKFFVGLFALVNPVGILPVFISMTSYQAAAGRDKTNLTA
NLSVAIILWISLFLGDAILTIFGISIDSFRIAGGILVVSIAMSMISGKLG
EDKQNKQEKTETAVRESIGVVPLALPLMAGPGAISSTIVWSSRYHSWQNL
LGLTVAIALFAFCCWLLFRAAPLLVRLLGQTGINVITRIMGLLLMALGIE
FIVTGIKAIFPGLL
>YP2225 marC2, multiple antibiotic resistance protein
MLSIFELFKAVGLGLVLLLPLANPLTTVALLLGLSGNMTREERNNQSLMA
AIYVFFIMTIAFYAGQIVMSTFGISIPGLRIAGGLIVAFIGFRMLFPQQS
AEDTQLEAKSQDLKKRKSINIAFVPLAMPSTAGPGTIAMIISSAATMKDQ
TMFAPWVLAIAPVITFLCVSLILWGSLLSSGAIMRWVGKSGIEAISRLMG
FLLVCMGVQFIINGVLELISTYQPVMA
>YP3312 marC3, putative membrane protein
MIAATVLLFLIMDPLGNLPIFMSVLKHLEPKRRRVVLIRELLIALILMLI
FLFAGEKILLFLNLRTETVSISGGIILFLIAIRMIFPSSESNVTGLSAGE
EPFLVPLAIPLVAGPSILATLMLLSHQYPNQLSHLVLALMIAWGLSAAIL
LMSNLFLRLLGSKGVSALERLMGLILVMLSTQMFLDGVRAYLAI
>YP3002 nrfG5, TPR-repeat-containing proteins
MLKIFNTIIIIPVMIFLLSGCLSQQGLSSQGLSTKEFSYRESILIKANNQ
IGLIKLYRESLKNKEDESIRVKLANAYYLSGDSHSSLYYLQPISHKPNVS
IYLLQIKNLINEGDNSGATTVLHRLLSIAPHNPEAHNLKGIILANRGDTA
GARTAIVQSQALFIQEDIARNNIAVISMLDNRYEDAVKILLPDYLSGKRN
NLILHNLVFALIKMGDTRYAKNIIEAERLSDNADELVLALSQVDSFPQEQ
SFIREK
>YP1738 ogl, oligogalacturonate lyase
MAKGKQIPLTYHTYQDASTGAQVTRLTPPDVTCHRNYFYQKCFTRDGSKL
LFGGAFDGPWNYYLLDLNSRVATQLTEGRGDNTFGGFLSPEDDALFYVKD
GRNLMRVDLATLEENVVYQVPEEWVGYGTWVANSDCTKLVGIEIKREDWQ
PLTDWKKFHEFYFTKPCCRLMRVDLKTGESAVILQENQWLGHPIYRPYDD
STVAFCHEGPHDLVDARMWLINEDGSNMRKVKTHAEGESCTHEVWVPDGS
ALVYVSYLKGSSDRFIYSADPVTLKNRQLTSMPACSHLMSNYDGTLMVGD
GSDAPVDVQDNSGYKIENDPFLYVFNIKNGTQHRIARHDTSWQVFEGDRQ
VTHPHPSFTPDDKQVLFTSDVHGKPALYMVTLPESVWQ
>YP2747 pilF, putative fimbrial biogenesis protein
MKLTKLWRVCLVVSVLTGCSGTPPENTSQAVAGQTRLQLGLAYLAQGDLT
AARKNLEKAVEADPQDYRTQLGMAFYAQRIGENSAAEQRYQQAMKLAPGN
GTVLNNYGAFLCSLGQYVSAQQQFSAAALLPDYGQVADSLENAGYCFLRA
NQDKQARVLLSRALKYDPDKGEPLLAEAQRHFGEGNRAQAQLLLDVYQHT
LPASAESLWLQIRFAALAGRQDSVQRYGKQLARSFPQSKQYQHFLANEY
>YP0259 ppdD, putative prepilin peptidase dependent protein D precursor
MAKHQGLTLQKGFTLIELMVAVAIIAVLSGIGIPSYQRYIQKAALTDMLQ
AIVPYKMAVELCALEQSNLDSCNAGSNGIPAGQVSRYINAINIAKGVITL
SGQHTLTGLTLAISPTRNSNGNLVWARTCTATDSAMTDSCKAVFRFNDKA
PSNG
>YP2850 pppA1, putative type IV prepilin peptidase
MMMMGMLQEKLYSLNEPLGLIEVNMMDIQVFFVSYLIFGAMVGSFLNVLI
YRLPIMLANLSSRSESHGEEIKMRSHLRNINLFQPGSFCHHCNESIPIKY
NIPILGWIFLRGASRCCNKKISTRYLFIEVLAVIQTLLVLMIFKEDLLIC
TSLVLIWSLTALAFIDFDTYLLPDCMTIPLLWLGLLINIDTVFAPLTSAV
LGAVSGYLFLWLSYWLFKIVRGVDGMGYGDFKLMAALGAWFGVSAVPFLI
LFSSFFGLVAYAIFYFFDKKDNGKEINYIAFGPYISLAGVLYLFLGSHVT
NLFS
>YP3009 pppA2, putative membrane protein
MDVIRLSLIVLIVSQLLFVCYSDIRHRIISNKFIISISFNAIIFSLVMHH
TVSIIIPIVALFIGYIIFHFNVMGGGDVKLITVLLLALTAEQSLNFIIYT
AVMGGVVMVVGLLINRVDIQKRGVPYAVAITAGFLSSVLI
>YP1288 psaB, chaperone protein PsaB precursor
MKNLFFSAYKKVFSYITSIVIFMVSLPYAYSQDVVVNTTKHLFTVKIGTT
RVIYPSSSTKGVSVSVANPQDYPILVQTQVKDEDKTSPAPFIVTPPLFRL
DAGLQGRVRIIRTGGKFPEDRETLQWLCLTGIPPKNGDAWGNTQNNPKNS
SPTMDIQMSISTCIKLLFRPDKVKGDPTDSADSLTWRYKGNYLEVNNPTP
FYMNFYSLRIGDEKINLSDLGSKDEIKNGSYVPPFSSRDFIIPVKNKGKA
TEVFWQVINDNGGVSREFKSTVQ
>YP1287 psaC, outer membrane usher protein PsaC precursor
MKKLIVQFTTITLLMSTSFLVGAQRYSFDPNLLVDGNNNTDTSLFEQGNE
LPGTYLVDIILNGNKVDSTNVTFHSEKSPSGEPFLQSCLTKEQLSRYGVD
VDAYPELSPALKNSQTNPCVNLAAIPQASEEFQFYNMQLVLSIPQAALRP
EGEVPIERWDDGITAFLLNYMANISETQFRQNGGYRRSQYIQLYPGLNLG
AWRVRNATNWSQSGDRGGKWQSAYTYATRGIYRLKSRVTLGESYTPGDFF
DSIPFRGVMLGDDPNMQPSNQRDFIPVVRGIARSQAQVEIRQNGYLIYST
VVPPGPFELSDVIPSKSGSDLHVRVLESNGASQAFIVPYEVPAIALRKGH
LRYNLVAGQYRPANADVETPPVAQATVAYGLPWNLTAFIGEQWSRHYQAT
SAGLGGLLGEYGALSSSITQATSQYHHQQPVKGQAWEVRYNKTLQASDTS
FSLVNSQYSTNGFSTLSDVLQSYRQSGSGDNRDKIDENSRSRDLRNQISA
VIGQSLGKFGYLNLNWSRQVYRGPIPAKNSLGIHYNLNVGNSFWALSWVQ
NANENKNDRILSLSVSIPLGGHHDTYASYRMTSSNGSNDHEIGMYGQAFD
SRLSWSVRQAEHYGQPNSGHNSGSLRLGWQGSYGNIAGNYYYTPSIRQLS
ADVSGGAIIHRHGLTLGPQINGTSVLVEVPGVGGVTTTEDRRLKTDFRGY
SIVSGLSPYQEHDIVLETADLPPDAEVAKTDTKVLPTEGAIVRASFSPQI
GAKALMTITRANGQTIPFGAMASLVNQSANAAIVDEGGKAYLTGLPETGQ
LLVQWGKDAGQQCRVDYQLSPAEKGDTGLYMLSGVCH
>YP3620 secA, preprotein translocase SecA
MLIKLLTKVFGSRNDRTLRRMQKVVDVINRMEPDIEKLTDTELRAKTDEF
RERLAKGEVLENLIPEAFAVVREASKRVFGMRHFDVQLLGGMVLNERCIA
EMRTGEGKTLTATLPAYLNALSGRGVHVVTVNDYLAQRDAENNRPLFEFL
GLSIGINLPNMTAPAKRAAYAADITYGTNNEFGFDYLRDNMAFSPEERVQ
RQLHYALVDEVDSILIDEARTPLIISGPAEDSSEMYIRVNKLIPKLIRQE
KEDSDSFQGEGHFSVDEKSRQVHLTERGLILIEQMLVEAGIMDEGESLYS
PANIMLMHHVTAALRAHVLFTRDVDYIVKDGEVIIVDEHTGRTMQGRRWS
DGLHQAVEAKEGVEIQNENQTLASITFQNYFRLYEKLAGMTGTADTEAFE
FSSIYKLDTIVVPTNRPMIRKDLADLVYMTEQEKIGAIIEDIRERTANGQ
PVLVGTISIEKSEVVSAELTKAGIEHKVLNAKFHAMEAEIVSQAGQPGAV
TIATNMAGRGTDIVLGGSWQSEIAALEDPTEEQIAAIKAAWQIRHDAVLA
SGGLHIIGTERHESRRIDNQLRGRAGRQGDAGSSRFYLSMEDALMRIFAS
DRVSGMMRKLGMKPGEAIEHPWVTKAIANAQRKVESRNFDIRKQLLEYDD
VANDQRRAIYSQRNELLDVSDVSETINSIREDVFKTTIDSYIPTQSLEEM
WDIEGLEQRLKNDFDLDMPIAKWLEDEPQLHEETLRERILQQAIETYQRK
EEVVGIEMMRNFEKGVMLQTLDSLWKEHLAAMDYLRQGIHLRGYAQKDPK
QEYKRESFAMFAAMLESLKYEVISVLSKVQVRMPEEVEALEVQRREEAER
LARQQQLSHQTDNSALMSEEEVKVANSLERKVGRNDPCPCGSGKKYKQCH
GRLQ
>YP0067 secB, protein-export protein
MSEQNNTEMAFQIQRIYTKDISFEAPNAPQVFQQDWQPEVKLDLDTASSQ
LAEDVYEVVLRVTVTASLGEETAFLCEVQQGGIFSVAGIEGTQLAHCLGA
YCPNILFPYARECITSLVSRGTFPQLNLAPVNFDALFMNYLQQQAEGEVE
GVEQRQDA
>YP0742 secD1, protein-export membrane protein SecD
MLNRYPLWKYLMLIVVIFVGLLYALPNLYGEDPAVQITGARGIAASETTL
VQVRDVLEKDNIASKSIALENGAILARFRDPDVQLRAREALVEALGDKYV
IALNLAPATPSWLAKLGAEPMKLGLDLRGGVHFLMEVDMDTALGKLQEQT
MDTLRTDLREKNIPYATVRKLDNYGVEVRFRDDKARNDAISYLSSRHRDL
VFSSNGSNTLKAVMSDERLREAREYAVQQNITILRNRVNQLGVAEPLVQR
QGSDRIVVELPGIQDTARAKEILGATATLEFRLVNTNVDASVAASGRVPG
DSEVKNTREGRPVVLYKRVILTGDHITDSTSSTDEYNQAQVNISLDSAGG
STMSNFTKDNIGKPMATLFVEYKDSGKKDANGRSILVKQEEVINVATIQS
RLGNSFRITGIDNPAEARQLSLLLRAGALIAPIQIVEERTIGPTLGSQNI
AQGLEACLWGLAVSILFMVVYYRKFGVIASTALMANLVLIVGVMSLLPGA
TLTMPGIAGIVLTLAVAVDANVLINERIKEEYRNGRTIQQAIHEGYKGAF
SSIVDANITTLITAIILYAVGTGSIKGFAITTAIGVVTSMFTAIVGTRAI
VNLLYGGKRINKLSI
>YP3116 secE, preprotein translocase SecE subunit
MTGWFMSANTEAPGSGRGLETAKWLIVAVLLVVAIVGNYYYREYSLPLRA
LAVVVIIAVAGAVALMTAKGKATVAFAREARTEVRKVIWPTRQETLHTTL
IVAAVTAVMSLILWGLDGILVRLVSFITGLRF
>YP0743 secF, protein-export membrane protein SecF
MPSSTCFTAASALTSCLFEEYVVAQDYTVEQLNYGRKVYDFMRWDYVAFG
VSLLLLVASIVVMSTKGFNWGLDFTGGTVIEINLENPADLDQLRDTLQNA
GFESPILQNFGSSRDVMVRMPPATGTAGQELGNKIISVINESVDKNASVK
RIEFVGPSVGSDLAQAGALALLVALLSILVYVGFRFEWRLALGAVISLAH
DVVITMGILSLFHIEIDLTIIASLMSVIGYSLNDSIVVSDRIRENFRKIR
RGTPYEIMNVSLTQTLSRTIMTSATTLMVVLMLFIFGGAMLQGFSLTMLI
GVTIGTVSSIYVASALALKLGMKREHMLQPKVEKEGADQPSILP
>YP0584 secG, protein-export membrane protein
MYEALLVFFLLISIGLVALIMLQQGKGADMGASFGAGASATLFGSNGSGN
FMTRMTAVLATLFFVISLILGNMSSNQGQKSSEWENLGQPLKTEQTATPV
APVKPSSDIPQ
>YP0227 secY, preprotein translocase SecY subunit
MAKQPGLDFQSAKGGLGELKRRLLFVIGALIVFRIGSFIPIPGIDATVLA
KLLEQQRGTIIEMFNMFSGGALSRASIFALGIMPYISASIIIQLLTVVHP
ALAEIKKEGEAGRRKISQYTRYGTLVLAIFQSIGIATGLPNMPGMQGLVI
NPGFAFYFTAVVSLVTGTMFLMWLGEQITERGIGNGISIIIFAGIVAGLP
PAIAHTIEQARQGDLHFLLLLLVAVLVFAVTFFVVFIERGQRRIVVNYAK
RQQGRRVYAAQSTHLPLKVNMAGVIPAIFASSIILFPATIASWFGGGTGW
NWLTTISMYLQPGQPLYVLLYASAIIFFCFFYTALVFNPRETADNLKKSG
AFVPGIRPGEQTAKYIDKVMTRLTLIGAMYITFICLIPEFMRDAMKVPFY
FGGTSLLIVVVVIMDFMAQVQTLMMSSQYESALKKANLKGYNR
>YP0241 smf, Predicted Rossmann fold nucleotide-binding protein involved in DNA uptake
MLAAELWLRMTQVKGLGVVKRSALAKRLLASGDIHPGRLAAYGLDSQQCH
QFAQLSPRYIADTLEWLSDPNHHLLTYGEPGYPPRLVHIAGAPLVLFVSG
ELDVLYRPQIAMVGSRHFSHYGEQWGRYFASELARTGLVITSGLAVGIDG
ICHQAALNIQGRTIAVLGSGLENIYPQRHSRLAKEIEYQGGALVSEFLTT
ALPIAAHFPRRNRIISGLSDAVLVVEATLKSGSLITARYAMDQGRDVFAL
PGPLGSASSEGTHWLIQQGAYLATSVKDVSEQVSGSLQWLSLPEEVIISS
PQEQVELPFADVLANVGDEVTPVDVVAERAGQPVQDIASKLLELELAGWI
AAVPGGYVRIRRAGHVRRSNLLI
>YP2404 smfA, putative mannose-resistant/Proteus-like fimbrialprotein
MSNFKKSVLVAAVLSLSAFAANAADQGKGKVTFTGSIIEAPCSITSEAAD
QVVELGQISTTSLANMGSSEPRSFSIGLEKCDVATMKNVSVTFDGTPDGV
DAEMLKLIGLADGAGIVITDEAGATIKRGVASVGKTLDQGSNSLKFSAYL
KGTSADEGSVVPGEFSSVANFTLAYN
>YP2013 sohB, peptidase family U7 protein
MELISLYGLFLAKVVTIVVAIGAVVLLVVSQGMRRQGQRGELNLVDLGEQ
YKETQREMRLARMSHAEQKAWVKEFKKQEKADQKLKKQRAKSGAVAAVKP
CLYVIDFKGSIGAQEVSSLREEISAILAVATAQDEVLLRLESPGGVVHGY
GLAASQLARLRQRGIRLTVAVDKVAASGGYMMACVADRIICAPFAIIGSI
GVVAQIPNFHRLLKKNDIDVELHTAGEFKRTLTLFGENTEQGREKFREDL
NETHLLFKQFVQQQRPSLDIDAVATGEHWFGTQAKEKGLVDAIGTSDDLL
IAEMDNHEVIGVRYSHRKRLIERFMGSATESVDSLLLRWWQRGEKPLL
>YP1962 sppA, protease IV
MRTLWRIIAGFFKWTWRLLNFTRELILNLFLALLILIGVGIYFQFQSKPV
EPVKGALLVNLSGVIVDQPAINNKLRQWGRELLGASSNRLQENSLFDIVE
TIRLAKDDDNINGLVLSLSDLTGADQSSLQYIGKALREFRDTGKKIYAVG
DSYNQTQYYLASFANKIYLSPQGAVDLHGFASNNLYYKSLLENLKVTTNI
FRVGTYKSAVEPMIRNDMSAAAREADSRWVGGLWQNYLTTVSANRRLTPE
QLFPGAAGVISGLQVAGGSQAKYALDSKLVDQLAARPEVESALVEAFGWN
KKTNDFNYISIYDYQPTPAPQQGEQIAVLFANGAIIDGPQPPGNVGGDTL
AAQIRQARLDPKIKAVILRVNSPGGSVSASELIRAELAALRAAHKPLVVS
MGGMAASGGYWISTPANYIVASPSTLTGSIGIFGVINTFQNSLASIGVHT
DGVATSPLADVSLTKALPPEFSQMMQINIENGYKTFIDLVATSRHKTPEQ
VDQIAQGHVWIGLDAKSNGLVDQLGDFDDAVKKAAELAKLKTWQLNWFVD
EPSLSDLILGQMSASVHAMLPAAIQTWLPAPLSAMALAVKDQPGLFNTLN
DPQNRYALCLTCGDVR
>YP3271 tatA, Sec-independent protein translocase protein TatA
MGSIGWAQLLIIAVIVVLLFGTNKLRTLGSDLGASIKGFKKAMGDDSQTP
PTNVDKTSNDADFAKSITEKQQPVAKAEESKSHEKEQG
>YP3272 tatB, Sec-independent protein translocase protein TatB
MFDIGFSELLLVLVIGLVVLGPERLPVAVRTVSGWIRTLRSLAATVQNEL
AQELKLQELQDSLKKVEQAGLQNLTPELKASMDELKEAAEALKRSYHVDA
GSEAPHTIHNPLVTEPEAIHDGVTPAEPATQVSALAQAPNILEAGTASVV
DSVVEAAPVTTVKSVVQGEVLVKSTPVQEVGLADVMDKPVTKQQIDTIDS
HGTDLSSAGPSRIHQPGGDQ
>YP3273 tatC, Sec-independent protein translocase protein TatC
MAVDDTQPLISHLIELRKRLLNCIITILVVFLVLVFFANDIYNLVSAPLI
KQLPAGASMIATDVASPFFTPIKLTMMVSVFVSAPMTLYQVWAFIAPALY
KHERRLMVPLLISSSLLFYLGMAFAYFVVFPLAFGFFAKTAPESVLIATD
ITKYLDFVMALFMAFGISFEVPIAIILLCWAGVTTPEALKKKRPYVFVGA
FVVGMLLTPPDVLSQTLLAIPMYLLFEVGVFFARFYTGKQRRAATEEDEG
IDSHPKAP
>YP1117 tatE, sec-independent protein translocase protein
MEGLSITKLLVVGILIVLLFGTSKLRTLGADLGAALKGFKKAMRNDDEVS
TSVLGETKMSAETKTVAETKAASDSQAAASVERKD
>YP1032 tolB, TolB colicin import protein
MKQAFRVALGFLVLWASVLHAEVRIEITQGVDSARPIGVVPFKWMGPGTP
PEEIGAIVGADLRNSGKFNPIDAARMPQQPSTAAEVTPAAWTALGIDAVV
VGQVQPSADGSYVVSYQLVDTSGSAGSILAQNQYKVTKQWLRYSAHTVSD
EVFEKLTGIKGAFRTRIAYVVKTNGGKFPHELRVSDYDGYNQFVVHRSPE
PLMSPAWSPDGSKIAYVTFESGKSALVIQTLANGAIRQVASFPRHNGAPA
FSPDGTKLAFALSKSGSLNLYVMDLASGQISQVTDGRSNNTEPSWFPDSQ
NLAYTSDQGGRPQVYKVNINGGVPQRITWEGSQNQNADVSPDGKFLVLVS
SNGGAQHIAKQDLETGAVQVLTDTLLDETPSIAPNGTMVIYSSTQGLGSV
LQLVSTDGRFKARLPATDGQVKFPAWSPYL
>YP1035 tolQ, TolQ colicin import protein
MADMNILDLFLQASLFVKLIMLVLMGFSIASWAIIIQRTRILNAATRDAE
AFEDKFWSGIELSRLYQESQARRDTLSGSEQIFHSGFKEFARLHRANSHA
PEAVIDGASRAMRISMNRELEALETHIPFLGTVGSISPYIGLFGTVWGIM
HAFISLGAVKQATLQMVAPGIAEALIATAIGLFAAIPAVMAYNRLNQHVN
KLEQNYDNFMEEFIAILHRQAFASTESK
>YP1034 tolR, TolR colicin import membrane protein
MARVRGRKRRELKSEINIVPLLDVLLVLLLIFMATAPIITQSVEVNLPDA
TDSKTVSSDDNPPVIVEVSGVGQYTVVVDHQRMELLPSEQVVAEAQARLK
TNPKTVFLIGGAKEVPYDEIIKALNMLHQAGVTSVGLMTQPI
>YP0741 yajC, putative membrane protein
MSRLFYRTDFTLLILITIEEILMSFFISDAVASAGAPAQGNSMTSMLIML
VVFGLIFYFMILRPQQKRAKEHKKLMDSIGKGDEVLTSGGFIGRVTKVAE
TGYVVIALNDTTEVMIKRDFVAAVLPKGTMKAL
>YP1153 yapC, putaive autotransporter protein
MDKTLLAGAISLSLVILPVQVLAFTPNVVGITVNDEVVIHGIQNVRDGGV
INNGLVSDNAAITVTNGSSAGTANNTTVGDKGWLQITGALATGTIVNQGG
LLDTKTAGTVIDSQINDGGHMTLGLNSQSKGYLNIAAGAELFVTNNDPYI
SDVTTHNPALPANVMIENLNVAGLVEIGPSWKGTSIVPLPLSDVLGPVLV
TRINNVTLQGGDINLMAYSAGGQFNRLEIENLSGQGNFAMTTQLASNTGD
FITVSQQATGQFGITVQDSGKEPQSADNLALVHINRGDAQFRLLNTGGVV
DLGVYQYGLYSQESNGSTDWYLATSTEELPGTTPNVTAPMLSSAAQGVLN
MAAAPRHILNAELSTLRQRQGELKADAEGTVGVWARYLTDDSRLSDNKNI
AFKNTLSGMEIGADKQLGLNRGNMLIGAFTSYSSSDVKSTHDANGDIRSY
GGGLYLTYLDQSGFYVDTVLKANRFNNKMNTQETRGEYNQNALTTSVESG
YQWPVYANLVLEPYGKVSYSRIGSADYTLSNGMVAEVAKADSVQGELGTV
LAASYSINQMTIKPYIKLAITREFTKSNAVAINNIGFDNDFSGNVGKYGV
GINATVANNTAIFAEVDYLNGSKIETPVTANIGFRLRF
>YP3347 yapE, putative autotransporter protein
MCCFNYSNKNPRMVMKTNRSTLSPCFRKTMIASLLVPLCSPLYSWAVQTA
SITDGSTMVISGGYDTEANNHSAVFVQGSGSTINGGSDVVIETTGVGAIG
AYASEGGSLGLTGSTINTENGVAFGVLNDKGTVNLQGGTITTKGQTAYGV
YSSGLGSNTDIHSSAITTSYSLTHAIYGAGGTGLTLNNTTLNTSGSGSYG
IYLDGSGGSLTGANNTINSTHATKGAGIYISAGGSNATLDNTTLNITKGA
VGVNVGEGSSITMDGLIATGNITNLFKVNGNASVSNANIELAAGGVLMAQ
GSSASNQAVIILNNVNVISNSGSTTLVDVNKDADVTINGGAYHSKGNNAK
GIWVRDNNSSLNVDNAVIITEGVNATAIENRGTAIVKNTTVITKGNNSHG
LYSEQSLDATNMAISTAGIGSIGVAAAKGGNLNLNDAFIETTGNSGMVLG
TFADSSISAKNITGISTGAGAYALWVDDGSSILLEESQITTQGQGAGGIY
ASNTGTGSHTAYTQVTLNNSQIHSEQGPGIWANGADINVDVKNGSQLTGG
NGLLVYASSNAGAASNVNVNGDNHAVLLGDIHAAENSNINLALNNNSVWT
GAATNAKQVDIDSSSIWNLTGDADVESMHVLGQMNFISNSSDTNSRAPYD
NFSTLTINSNVTGSGSFTFNVQLGDNDSPVDRLYVIGNASGDHGVQVINQ
GGLGALTTGDGINLITVDGETHSGSFTMSNSVSAGAYEYFLYKIDDYRWN
LQSNLINPGPGPEPEIEPEEIAYRPEVPGYIAAPWLNAFYGFTTLGSLHE
RRGSAEGAAEGFNQDSWGRIRGQHNNFDAGRFSYDSNIWFMQLGHDVYQA
KNAAGTQVTGGMMITLGKQNSDTRDRARAINPDLSIDTGKIKTEAYGFGG
YYTLMTEEGGYLDIVSQATLYRNNYESQHNTKHNGYGVVMSAEVGQPYPL
AAGWVVEPQGQLKYQYLHLSPKNFNDSISEIGGTDYSVGQVRGGLRLFSD
ASEKRDIKPYLTTDVLHQLGRNPQVTVATVDIRPDFTKTFWQGGAGVTAK
VNSQVDLYADAKYQKSFDGKLDGYLGNLGVKVSF
>YP2924 yapF, putative autotransporter protein
MNNHKIWRLSAVAVALLISGNSYADQTLHFAQQPHNTGDHTVIAAPEVNN
FSLADLTANAEGQAVDATNAGALSLRVEPTQGDAQANGVLVTSGTFTNQA
QGSITVSASSQDQHAVASGLQATDAYWSTLRNQGSIRATSNSLHGSAEVY
GIQAGLAFSDAAGDHYGDHMMLSNEGVMQVSATAEQDAFASGIYTNAGNG
VVNNGRLDVSAHASAGDARATGLHTLSANPSVDPDPWNPANPTHLMSNNG
SLSVTASGNNATASAISTEGEGVYIYNNGTLIVDAFSESAQGGASAYGIH
VLNGSATINSSGRILATATGGSQQQAYEVMADGSVVNIERYTLALGNETP
WAVSNGGSIVLGNGTQGADLVLMAGQASEGFAYGKEYSLDNLAYDTTSGQ
QSTVGGSIAGLYGITPDIKVIHSGSSSSSLGSAALVYAPDVSHAGVSALA
QRSSMEQASNIISSQLHSQLVSNAGCNQKLESADSCVFITPYAGEYRRDP
VTSGYSGQRYGVLLGQNQHFGDFQLGWHGGYESASTDFNGTSVGRKEEIN
TLMLGVQGGMKLSESLFIAATSTWFSSDTDYSDSNTYYGVGSQSGSYDSS
GLYTDVSVGNSWQLNRNYAMTPMVGLTHIWQQRDGYTVSSNNKNYDLIDT
RYSSYSDHAVALHAGVRLDGRYPLTNETLLKPFFNVGFQQMLYGDEITID
QSIPNSPVVGVSTKDKTTQGTFDLGMALVSDNGVSASLQLSGMVNSDRQD
FTGWANLGWAF
>YP3415 yapH, putative autotransporter protein
MLRLYMNTIFKVIWNASLNVWVVVSELAKGRIKTKSSRNLISEGVLPKFE
QSMVSKLFRKNLLALSLGSIVFLSTGPVFAADITVSTQAELSAALSNGTY
DKIILGADITLIGSLTVNMTSNQVVIDGQGKFGLTVNNTTNYGLVVSSGS
GTLTLQNMSKIDSANYYSMVVLNGANTAVNVIYNNIDFLGSSQLIYMGAY
GAATNSIMTFGDILNDVVVNDRAQEIGEVNKLAFTGRFHVTHTGSSVTSF
VSTGGANNTSTMDFASGADVKIDRTGSTGDLTSTGVNAFAYTFADGASFE
LIANQNVFSGTTTNRGLEIGSYNSIDGFGSGVKIVLQSRSDGSIISGNGI
DNATTNAAGINNNASGDANVIYNLGTGSILKATNTGILATKNANNASDIY
IRSAGDITAATGISATHNGTGTVKIKNDGTITSTTAGIAISSASIKEISV
DNTDGTITATAGTGVNVLASAILNLFGGTINTSATANGITFAGTEGGHTL
TDLTINLLGTGIALSNVAGVNLTLSNVTLNTLNGTALNSLTGLTLVDSLN
GRNTINIEGAGIGIAATNTELNTFDAEALDINVNGAGIGIQATGGGVNLS
ASNLIINVANTLGTALQITDGIDNTTTIGNEIQLNAENATAINFLGSSSK
TLNNNGTIKGSVIFAGVADHIINNNGTLDGTLTTGAGNDTLVLDSSSQSN
DVINLGDGNNSVTIQNGATVSSIITGNGNDTFTINGMSVGSTYLGSLDAG
TGLNTLNFNASTDELAAATSLQGFTNINLVDSHITLVSDDNIGSGMVNID
SSSELLFGSTFDGILHATLGAGTGSAIVNNSANVSLEQASMFAGTWQVNQ
GGALTASNSNQLGSAKIGLDGTLNLDNIALFNHVLTGNGTLNVAKNLATT
AFDFGSTVGGAFSGIVNLTKTTFALSADNAAALASATLKLSDDSVTTVGT
TDRTLHGLDLSGGTLIFDGAVPQSQTSGVVTVTDLALNSGTVNITGSGSW
DNTDPLATNVSILEQDRAGSTLELINATNVTGDIDALDLLVNGTAITSGT
QGVQSAIQQGGSTVANAIHNYGLASSNSNGDSGLYVNYTLSALELLADGA
DALLLATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGSNRYEGTTT
VTAGELILGANGAFGQTSLLDIASGASANINGYSQTVGAVTNVGTVTLGS
GGVLTSGLLTNGGILDLTGGALNLTAGGASTVAGGLTGAGTLNINGGNLS
VSAANSGLSGQTHIADVASVTLTDTGTLGTSAVEVLGTLNLNGANAAMTN
VLSGDGTINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLGASSATVN
LGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANNSGFLGQY
ALAGNSKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNSVTGSGVL
QVTDDAEVTLTSSNGVSNAVTIDIADATLNLDDIALFNHVLTGNGLLNVA
KNDASTAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARATLKLSDDS
VTTVGATDRTLHGLDLNGGTLIFDGSPPQSQANGVVTVTDLALNSGTISI
TGAGNWENEHPVTPPNVSLLEQDRGDILLELINAANVTGNANNLDLLVDG
TAITSGTQGVESAIQQGGSTVANAIHNYGLTSSNGNGGSGLYVNYTLSAL
ELLANGANALLLATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGNN
RYEGTTTVTAGELILGANGAFGQTSLLNIASGASANINGYRQTVGAVTNS
GAVTLGNGGVLTSGLLTNGGILDLTGGALNLAAGGSSTVAGGLTGAGTLN
INGGDLAVSATNSGLSGQTHIADVASVTLTGTGTLGTSAVEVLGTLNLNG
ANAAMTNVLSGGGVINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLG
ASSATVNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANN
SGFLGQYALAGNSKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNS
VTGSGVLQVTDDAEVTLTSSNGVGNTVKVDIADATLNLNDIALFDHVLTG
NGTLNVAKNLATTAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARAT
LKLSDDSVTTVGTTDRILHGLDLNGGTLIFDGSPPQSQANGVVTVTDLAL
NSGTISITGAGNWENEHPVTPPNVSLLEQDRGDILLQLIDADNVTGNAND
LELMINGTTISAGQGVQSTVQQGGYTVANATHNYGMTSNGGSGLYVNYTL
SALELLADGANALLLATESGLTANRELNAELSGVGGLVVDAQNGALTLAN
GNNRYEGTTTVTAGEFILGANGAFGQTSLLNIASGASANINGYRQTVGAV
TNTGTVTLGNGGELTSTDTLINTGMINVTDGILNLENGGASSISGGLTGN
GILNIKGGDFTISIDNNGLAGQTNISDGASVTLGNGGTIIGTGNLGSSVI
DVLGDLNLVADNSLANVISGDGTINTTATVTLSGNSSFSGAHQIGTNGEL
TVGQASNLGASSATVNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGG
ADTALTANNSGFLGQYALAGNSKLTVASTNNLGASSSVALAGTGDTLSLS
GFNGTFGNSVTGSGVLQVTDDAEVTLTSSNGVSNAVTIDIADATLNLDDI
ALFNHALTGNGLLNVAKNDASTAFDFGATVGGAFTGTVNLNNSTFDLSGN
NTTVLAQATLKLSSGNLTSVGNGVQNIGTLAMNGGTLLFDNIVDNAGIIT
SDGTIAANSINTTGGGEVRVNLPSNLAPSLDGLSVMELDEGEIIVTLATG
AATGTGHELTLTDENGDPISAVTYQGVHNAGSTSAAATGSFNYGMTTGED
YDGLYVNYGLTALELLSTGSEALVLTAILANNGTQSNDLSAQITGSGDLA
FASANDGSTASLSNSTNSYTGTTWVSSGNLRLDADSALGQTSLLAMSTAT
HVDINGTQQVVGELATEGGSTLDLNDGKLTVTGGGQIDGALTGGGELVLS
GGLLNVSYDNAGFTGSTDIANGAVAHLSQAQGLGNGTINNNGTLHLDNTI
GTLFNALTGSDGEVLLSNNASVQLAGDNSGYSGLFTNQAGSILIANSAEH
LGGSSIANSGALILDTGSVWELTNTISGTGTLVKRGSGTVKIEGDTVSAG
LTTIEEGLLQLGSSAVTQTLSLEESLQERALLVSFASNMANLTSNVLITA
NGSLGGYGQVTGNVENYGNLIMPNALTGGDFGTFTIDGNYTGDEGMITFN
TILAGDTSVTDRLVITGDTAGQSYVTVNNIGGVGARTFEGIKIIDVGGDS
AGQFTLNGRAVGGAYEYFLYQGGASTPDDGNWYLRTEADDRRPEPASYTA
NLAAANNMFVTSLADRMGETLYTDVFTGEQKTTSLWLRNEGSHNRSRDDS
GELKTQDNRYVMQLGGDVAQWSRNAQDLWRVGVMAGYANSSSSTVAQVAG
YRSTGSVDGYSVGIYGSWLADNADDTGAYVDSWVQYSWFDNRVSGQDLAT
EKYDSKGFTASVEGGYAFKVGESVNQSYFIQPKAQVVWMGVKADDHTETN
GTVISGDGNGNIQTRLGAKAFINPSDKAKVSGPAFKPFVEANWIHNTKDF
GTTLDGVTVKQAGTANIAELKLGVDGQVNSQLNLWGNIGQQVGNKGYSET
SVVLGVKYNF
>YP4009 yidC, probable membrane protein
MDSQRNLLLIALLFVSFMIWQAWQVDNNPQPTAQTTQQTTNTATGDKASQ
AVPGSGQGQLITVKTDVLSLTINTRGGDIEQANLLAYPDTLGSSNTFELL
ETTPSFVYQAQSGLTGKNGPDNPANGDRPLFEVPQTSFVLADGQDELRIP
LTFTSKDGSVFIKTFVLKRNDYAIGVDYHVNNASAAPLELTLFGQLKQSI
NLPKKRDTGSNNFALQTYRGAAYSSDETKYKKYSFSDIEDKNLDITTKGG
WVAMLQQYFATAWIPAANETNTFYSAELGNGLAAIGFKGAPVVIQPGEQK
QLSATLWVGPEIQNKMAEIAPHLDLTVDYGWLWFISQPLFKLLKFIHSFV
GNWGFSIIVITFIVRGIMYPLTKAQYTSMAKMRLLQPKLAAMRERIGDDK
QRMSQEMMALYKAEKVNPLGGCLPLIIQMPIFLALYYMLMSSVELRHAPF
ILWIHDLSAQDPYYILPILMGITMYFIQKMSPTTVTDPMQQKIMTFMPVI
FTVFFLWFPAGLVLYYIVSNLVTILQQQLIYRGLEKRGLHSREKKK